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Abstract
Unlike many teleosts, the estuarine killifish, Fundulus heteroclitus (mummichog),
does not demonstrate a shift from estrogens (such as 17β-estradiol; E2) to progestogens
(such as maturation inducing steroid; MIS) during ovarian development. While these
hormonal changes associated with ovarian development have been previously described
in mummichog, the primary focus of the current study was to extend those studies by
investigating whether these hormonal patterns are associated with changes in gene
expression within the steroidogenic pathway. Blood (plasma), ovary (tissue and ovarian
follicles), liver, and brain were collected from female mummichog at various stages of
maturation, classified as cortical alveolus, vitellogenic, early mature, late mature, and
ovulating. Testosterone (T), E2 and MIS, measured from plasma and in vitro ovarian
follicle incubations, confirmed that T and E2 production correlate with vitellogenesis and
final maturation in mummichog, whereas MIS correlates with only final maturation,
further establishing the lack of an E2 drop prior to maturation. To determine patterns in
mummichog steroidogenic and hormone signalling pathways, gene expression of ovarian
StAR (steroidogenic acute regulatory protein), cytochrome P450 enzymes, estrogen
receptors (ERs), and gonadotropin receptors, along with hepatic vitellogenin (VTG1) and
ERs, and brain P450 aromatase (P450arom; CYP19b), were determined by qPCR across
ovarian development. The expression of P450arom (CYP19a1; converts T to E2), ERα,
StAR (initiates cholesterol transport), P450scc (P450 side chain cleavage; converts
cholesterol into pregnenolone), and hepatic VTG1 are associated with patterns of E2
levels in maturing mummichog as expression remained continuously high or increased
into late maturation; however, these genes did not follow trends exhibited in other
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teleosts. CYP17 expression (converts pregnenolone to 17α-hydroxypegnenolone and then
dehydroepiandrosterone, or converts progesterone to 17α-hydroxyprogesterone and then
androstenedione) was not associated with E2 patterns in mummichog, or other teleosts;
expression decreased across maturation in mummichog. The secondary focus of this
thesis was to determine the effects of an exogenous estrogen (EE2; 17α-ethinyl estradiol)
on maturing follicles. Although many teleost species exposed to environmentally-relevant
concentrations (e.g., <10 ng/L EE2) in vivo respond with a decrease in egg production and
reproductive steroid levels, mummichog do not exhibit similar effects at much higher
concentrations (e.g., >100 ng/L EE2). Ovarian follicles (cortical alveolus, vitellogenic,
early mature, and late mature) were exposed in vitro to 50 – 250 nM of EE2 in vitro for
24 hours. While other studies have suggested that ovarian LHr and P450arom expression
are estrogen-responsive in fish, addition of EE2 in vitro had no effect; T and MIS
production were also unaffected. Overall, these studies confirm high levels of follicular
E2 across maturation, accompanied by increasing or continuously high expression of
ovarian ERα, StAR, P450scc, and P450arom, hepatic VTG1 and brain P450arom in
maturing fish. The tolerance exhibited by mummichog to exogenous estrogens could be
partially attributable to continuously high levels of E2 present in the maturing ovary, as
EE2 during follicular incubations has no effect on presumed E2-responsive genes.
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Chapter One: General Introduction

1.0 Introduction
This thesis is focused on characterization of aspects within the reproductive
endocrine system during ovarian development in the estuarine killifish, Fundulus
heteroclitus (mummichog). In previous studies, ovarian E2 (17β-estradiol) during
maturation was observed to be regulated differently than in other teleosts. This difference
is explored in the context of mummichog’s relative insensitivity to exogenous estrogen
exposure in comparison to other fish species. Chapter one provides an overview of the
fish reproductive endocrine system in general, and the mummichog system in particular.
Chapter two describes the experimental work undertaken for the thesis in manuscript
format. Chapter three is a summary including a description of the integrative nature of the
work.
1.1 Female Fish Reproductive Physiology
In the classical definition, endocrine glands secrete chemical messengers
(hormones) directly into the circulatory system, to be transported to a target organ; the
hormones control responses such as growth, reproduction, and metabolism (Rushton,
2009). Reproductive processes and strategies have evolved extensively among fish
(Miller and Kendall, 2009), and are controlled and regulated by a balance and
interconnectivity among the hormones of the hypothalamus, pituitary and gonads,
referred to as the hypothalamus-pituitary-gonadal (HPG) axis (Ramezani-Fard et al.,
2013). Gonadal hormones control reproductive processes such as spawning,
spermatogenesis (production of sperm), and oogenesis (production of eggs) (Miller and
Kendall, 2009).
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1.1.1

The Hypothalamus-Pituitary-Gonadal (HPG) Axis (Overview)
The HPG axis controls reproduction in fish, through the development of

reproductive tissues and coordination of complex processes that occur during the annual
reproductive cycle (Figure 1.1) (Thomas, 2008). The brain facilitates the release of
gonadotropin-releasing hormones (GnRHs) (Yu et al., 1997). The GnRHs are tropic
peptide neurohormones produced in the neurons of the hypothalamus, which are released
from their neural terminals to stimulate the release of gonadotropin hormones (GtH),
from gonadotropes of the pituitary (Parhar et al., 2002; Zohar et al., 1995). Binding of
GnRH to specific receptors on the plasma membrane of gonadotrope cells in the pituitary
causes the activation of intracellular signaling pathways, which regulate the release of
gonadotropins from storage (Thomas, 2008). The pituitary gland is able to facilitate
reproduction in fish by using a dual GtH system: FSH (follicle stimulating hormone) and
LH (luteinizing hormone), which are produced in two distinct gonadotropes of the
pituitary (Ohkubo et al., 2013).
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Figure 1.1. Stimulatory processes in the hypothalamus-pituitary-gonadal (HPG) axis.
Descriptions of the processes can be found in sections 1.1.1 and 1.1.2. A primary role of
FSH is to stimulate E2 production, and a primary role of LH is to stimulate MIS
production. (Modified from Clelland and Peng, 2009.)

1.1.2

Gonadotropin, Steroid and Vitellogenin Regulation
FSH and LH are glycoprotein hormones consisting of both an alpha subunit and a

beta subunit; the beta subunit is unique for each gonadotropin (Ohkubo et al., 2013). In
female fish, FSH and LH are released into the bloodstream and then bind to their
respective cell surface ovarian receptors (FSHr and LHr) (Ohkubo et al., 2013). FSHr and
LHr activation stimulates gonadal functions, including the synthesis and release of certain
steroid hormones involved in reproduction (Evans, 1999; Peter and Yu, 1997; Wang and
Ge, 2004). It was first determined in coho salmon, Oncorhynchus kisutch, that FSH is
4

primarily involved in regulating gonadal steroidogenesis in the early ovarian
developmental stages, especially during vitellogenesis (Swanson et al., 1991; Ohkubo et
al., 2013). During vitellogenesis, vitellogenin (a female-specific lipoprotein) is
synthesized in the liver under the stimulation of ovarian 17β-estradiol (E2), and is
secreted into the blood and transported to the ovary where it is taken up into the oocytes
to stimulate egg yolk protein production during development of the oocyte (Hoar et al.,
1983). FSH’s dominant role in vitellogenesis is to stimulate E2 production and release
from ovarian follicles into the bloodstream (Nagahama and Yamashita, 2008). In teleosts,
E2 plays a crucial role in sexual differentiation, gonadal development and steroidogenesis
(the synthesis of steroids) during the reproductive cycle (Menuet et al., 2005). E2 also
influences pituitary gonadotrope activity, which will in turn control the gonads through
the synthesis of gonadotropins (Menuet et al., 2005).
LH’s primary function, on the other hand, is to regulate the final stages of ovarian
development and spawning (Breton et al., 1998; Tyler et al., 1997), partially due to its
ability to stimulate 17α, 20β-dihydroxy-4-pregnen-3-one (17α, 20β-P), or maturation
inducing steroid (MIS), production from the granulosa cell layer of the ovarian follicle
(Figure 1.1; Clelland and Peng, 2009; Nagahama and Yamashita, 2008). In most teleosts,
17α, 20β-P is the most effective steroid in the induction of GVBD (germinal vesicle
breakdown) which occurs once a follicle is mature (Nagahama, 1983; Nagahama, 1994).
MIS is responsible for inducing resumption of meiosis in teleost oocytes (Nagahama and
Yamashita, 2008). The mechanism of MIS activity involved in oocyte maturation
involves a complex interaction between oocyte MIS receptors and signal transduction
pathways via inhibitory G-proteins (Nagahama and Yamashita, 2008). The MIS signal
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induces the formation of maturation-promoting factor (MPF) and further induces GVBD
and oocyte maturation (Nagahama and Yamashita, 2008).
1.1.3

Estrogen Receptor Activity
The principal mediator of E2 activity is the nuclear estrogen receptor (Marino et

al., 2006). Analyzing estrogen receptor activity furthers our understanding of how E2 is
regulated and how it is involved in other signaling pathways. The activation of steroids,
such as estradiol, can occur by both nuclear and membrane receptors. With membrane
receptors, the steroid binds to receptors on the cell surface, resulting in activation of ion
channels or intercellular secondary messengers (Thomas, 2008). With nuclear receptors,
steroids bind to the hormone response elements on a gene and alter their transcription
rates (Thomas, 2008). The gene expression of nuclear receptors is regulated by steroid
hormones, so expression rates will fluctuate in response to changes in steroidogenesis
(Thomas, 2008). The genomic effects of E2 are mediated by specific nuclear receptors
(ERs), which are able to modulate specific gene activity by acting as ligand-dependent
transcription factors; when receptors are bound to the dependent ligand, the target genes
will be activated (Menuet et al., 2002). In teleosts, two ER subtypes have been identified:
ERα and ERβ; there are two distinct forms of ERβ: ERβ1 and ERβ2 (Menuet et al.,
2002).
1.2 Steroidogenesis
Hormones are derived from cholesterol in the process known as steroidogenesis
(Figure 1.2), which involves a number of intermediates and enzymatic conversions prior
to their release from the gonads (Arukwe, 2008; Leusch and MacLatchy, 2003; Young et
al., 2005). The synthesis of the different classes of gonadal steroids depends on the
6

delivery of the substrate cholesterol, and its conversion by three enzymes belonging to
the cytochrome P450 superfamily (Young et al., 2005). Steroidogenic acute regulatory
protein (StAR) is a sterol transport protein which initiates cholesterol transport into the
mitochondria (Rone et al., 2009). Cytochrome P450 side-chain cleavage (P450 scc) is
located at the inner mitochondrial membrane and converts cholesterol to pregnenolone
(Young et al., 2005). Pregnenolone is a basal steroid that can serve as a substrate for
cytochrome P450 C17; P450 C17 can catalyze the hydroxylation of pregnenolone to yield
17α-hydroxypregnenolone and then dehydroepiandrostone, or the hydroxylation of
progesterone to yield 17α-hydroxyprogesterone (17α-HP) and then androstenedione
(Young et al., 2005). Testosterone (T) is created from the conversion of androstenedione
with the enzyme 17β-HSD (HSD: hydroxysteroid dehydrogenase), which is later
converted into 11-ketotestosterone (11-KT) in males. The synthesis of estrogens depends
on cytochrome P450 aromatase (P450arom), which uses T as a substrate for conversion
into E2; changes to P450arom are responsible for the drop in estrogen levels that can
occur in many teleosts prior to maturation (Young et al., 2005). During the maturation of
oocytes, post-vitellogenic follicles have to synthesize a large amount of MIS (Arukwe,
2008). MIS is produced from the conversion of 17α-hydroxyprogesterone to 17α, 20β-P,
with the enzyme 20β-HSD, which is believed to be initiated with a surge in LH
production (Barry et al., 1990; Young et al., 2005).
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Figure 1.2. The steroidogenic pathway, responsible for the production of sex steroids
such as MIS, T and E2 from cholesterol through multiple enzymatic reactions as
explained in section 1.2. (Modified from Young et al., 2005).
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1.3 The Ovarian Development Cycle
Ovarian development in teleosts varies from species to species, in both the
duration of the cycle as well as the mechanisms involved in regulating the cycle; the
duration of the cycle in fish can vary from a few days to a few years (Khan and Thomas,
1999). Oocyte maturation is the process whereby ovarian follicles develop (with an
enormous growth of oocytes due to accumulation of yolk proteins in cytoplasm) and
become mature (including germinal vesicle breakdown, chromosome condensation,
assembly of the meiotic spindle and formation of the first polar body) prior to ovulation,
which is required for successful fertilization (Nagahama and Yamashita, 2008).
Oogenesis (oocyte maturation) can be described in six major steps: formation of PGCs
(germline segregation), transformation of PGCs into oogonia (sex differentiation),
transformation of oogonia into oocytes (onset of meiosis), growth of oocytes while under
meiotic arrest, resumption of meiosis (maturation), and expulsion of the ovum from its
follicle (ovulation) (Patino and Sullivan, 2002).
The ovarian follicle, which surrounds each oocyte, consists of two major cell
layers: an outer thecal cell layer and an inner granulosa cell layer (Figure 1.3; Clelland
and Peng, 2009). As oocytes grow, follicle cells multiply and form a continuous follicular
layer (granulosa cell layer); the follicular layer changes in order to support, nourish and
regulate oocyte development in a continuous manner (Nagahama, 1994). In teleosts,
growth and development of ovarian follicles are dependent on the actions of
gonadotropin FSH and the steroid E2; whereas maturation of ovarian follicles is regulated
by gonadotropin LH and the steroid MIS (Nagahama and Yamashita, 2008). In the twocell type model, the thecal cell layer will secrete androgen substrates, such as T and 17α-
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HP, while under the influence of gonadotropins. In the granulosa cells, 17α-HP and
testosterone will be converted into MIS and E2 (Nagahama and Yamashita, 2008;
Yamashita et al., 1995). In this model, prior to ovulation, E2 levels decrease and allow for
significantly increased levels of MIS, which is required to complete maturation of the
oocyte (Nagahama and Yamashita, 2008). Human chorionic gonadotropin (hCG) is used
in experimental studies of ovarian development, as it is effective in inducing in vitro, and
sometimes in vivo, oocyte maturation and ovulation in some teleosts; hCG mimics LH
activity (Harvey and Hoar, 1979; Zuberi et al., 2011).
The stages of oogenesis in commonly-studied teleosts, e.g., zebrafish (Danio
rerio), are generally divided into growth/developmental stages and maturational stages
(Figure 1.4). The developmental stages of oogenesis encompass the primary growth,
cortical alveolus, and vitellogenic stage, and are predominatly regulated by increasing
levels of E2 and FSH. During primary growth (prior to stage 1), oocytes begin to grow in
size while the germinal vesicle (GV; oocyte nucleus) appears in the center of the oocyte,
and a single layer of follicle cells surrounds the oocyte, eventually forming a vitelline
envelope (Lyman-Gingerich and Pelegri, 2007). Stage 1 (cortical alveolus) is when the
cortical alveoli (bound vesicles) appear in the ooplasm and the vitelline membrane
contains three separate layers which surrounds the oocyte (Lyman-Gingerich and Pelegri,
2007). Stage 2 (vitellogenesis) is when oocytes undergo vitellogenesis and acquire large
amounts of vitellogenin, displacing cortical alveoli to the cortex of the oocyte (Clelland
and Peng, 2009; Lyman-Gingerich and Pelegri, 2007). Stages 3-5 are maturational stages,
which are commonly initiated with the drop in E2 levels and rise in MIS and LH levels.
The maturational stages of oogenesis allow for drastic morphological changes in
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accordance with the progression of meiosis, and allow for GVBD as well; the GV, which
is usually located in the center of the oocyte, migrates to the animal pole with hormonal
stimulation, where GVBD can occur (Suwa and Yamashita, 2007). Stage 3 (early
maturation) is when oocytes are able to respond to LH, secreted from the pituitary, and
MIS, synthesized and secreted from the follicle following MPF (maturation promoting
factor) stimulation (Yamashita, 2000). Stage 4 (late maturation) is when the germinal
vesicle migrates from the center of the oocyte to the periphery and the nuclear membrane
breaks down (Selman et al., 1993). Stage 5 (ovulated) is when mature eggs are ovulated
(oocyte is released from follicle complex and are ready for spawning; Lyman-Gingerich
and Pelegri, 2007).
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Figure 1.3. The two-cell type model in teleost oocytes. Major hormones, E2 (17βestradiol), MIS (maturation inducing steroid), T (testosterone) and17α-HP (17αhydroxyprogesterone), involved in oocyte growth and maturation outlined in the two
layers (theca and granulosa) of the oocyte are shown. Descriptions of these processes can
be found in section 1.3. (Modified from Clelland and Peng, 2009).

Figure 1.4. Stages of ovarian development in commonly-studied teleosts with a two-cell
type model, which are regulated by processes as explained in section 1.3 and Figure 1.3,
separated by oocyte development and oocyte maturation stages. Primary growth stage =
prior to stage 1; stage 1 = cortical alveolus stage; stage 2 = vitellogenic stage; stage 3 =
early maturation stage; stage 4 = late maturation stage; stage 5 = ovulated stage.
Germinal vesicle (GV) breakdown occurs when oocytes become fully mature in stage 4.
Regulation of hormones E2 (17β-estradiol) and MIS (maturation inducing steroid) are
depicted with relative increasing and decreasing arrows. (Modified from Selman et al.,
1993).
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In mummichog, however, thecal cells (endocrine cells which play an essential
role in producing androgen substrate required for ovarian estrogen biosynthesis
(Magoffin, 2005)) are not evident in the thecal layer (Nagahama, 1994). In mummichog,
granulosa cells are the major site of steroid synthesis, and respond to mummichog
pituitary extract in vitro (Petrino et al., 1989). The production of E2 and 17,20β-P does
not require the involvement of two cell types (Petrino et al., 1989). Petrino et al. (1989)
also concluded that 17, 20β-P plays a major role as a maturation inducing steroid in
mummichog, even though it is not the only active steroid produced by maturing follicles
(as E2 production remains high).
1.3.1

Shift in Steroidogenesis Prior to Oocyte Maturation
In most teleost ovarian development processes studied to date, there is a shift that

occurs between the developmental stages and maturational stages in the ovarian
development cycle; a shift from estrogenic to progestational steroid production when
follicles progress from vitellogenesis to a prematurational stage (Nagahama and
Yamashita, 2008). As mentioned earlier, E2 (regulated by FSH) is produced in correlation
with vitellogenesis; whereas MIS (regulated by LH) is produced in correlation with the
onset of maturation of oocytes. It has been demonstrated in several teleost fish that the
steroid 17α, 20β-P (MIS) is the most effective steroid in stimulating oocyte maturation
(Nagahama, 1983; Nagahama, 1987). In goldfish, Carassius auratus, E2 production
reduces greatly in the prematurational stage when compared to vitellogenic follicles
(Kagawa et al., 1984). Maximal production levels of T were reported in the tertiary yolk
stage follicles with hCG (LH analogue) stimulation (Kagawa et al., 1984In coho salmon,
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the concentration of E2 was reduced while the production of T and MIS increased with
advancing oocyte development (Van Der Kraak and Donaldson, 1986).
In mummichog, however, there is no shift detected as the levels of E2 are
consistently high in all stages of follicles (Lin et al., 1987). Ultimately, high levels of E2
coexist with high progestagen levels in mummichog (Lin et al., 1987). Lin et al. (1987)
also demonstrated that mummichog gonadotropins show a noticeable species specificity,
as mummichog follicles exhibit both a seasonal and size dependent responsiveness to
gonadotropins; the steroidogenic responses of mummichog ovarian follicles were found
to be very dependent on the stage of follicular development.
1.4 Endocrine Disrupting Compounds
There are numerous natural and anthropogenic chemicals discharged into
freshwater and estuarine systems that are capable of disrupting the endocrine systems of
aquatic organisms (Sumpter, 2005). Endocrine-disrupting chemicals (EDCs) have been
defined by the World Health Organization’s International Programme on Chemical
Safety (2002), as: “an exogenous substance which alters function(s) of the endocrine
system and ultimately causes adverse health effects in an organism, its offspring or (sub)
populations.” EDCs have the potential to disturb sensitive hormone pathways that
regulate growth and reproductive functions in aquatic organisms (Arcand-Hoy and
Benson, 1998).
Fish are primary targets for waterborne endocrine disruptors, many of which are
xenostrogens (synthetic or natural estrogen-mimicking or –blocking compounds)
(Menuet et al., 2005), making the impact of xenostrogens on aquatic ecosystems and fish
a subject of great interest. Reports of reproductive problems in North American and
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European freshwater and marine fish populations have sparked a wave of research, and
raised awareness on the potential risks of EDCs to human and environmental health
(Diamanti-Kandarakis et al., 2009; UNEP/WHO, 2013). The feminization of male fish
due to exogenous estrogen exposure has been demonstrated in several studies such as in
Kidd et al.’s (2007) whole-lake study with fathead minnow (Pimephales promelas),
which showed feminization in males following exposure to 5-6 ng/L of 17α-ethinyl
estradiol (EE2), and ultimately a near extinction of the species studied from the lake.
Schwindt et al. (2014) suggested that fish populations exposed to environmentallyrelevant EE2 concentrations may not recover from exposure, and recommended improved
wastewater processing technology to improve removal of bioactive chemicals such as
environmental estrogens. Understanding the mechanisms of action for xenostrogens is an
important step in evaluating the impact of these substances on fish reproductive
physiology, and of assessing risk to fish populations in vulnerable ecosystems
(UNEP/WHO, 2013).
1.4.1 EE2: 17α-Ethinyl Estradiol
The synthetic steroid EE2 (Figure 1.5A), is one of the most commonly-used active
ingredients for oral contraception and related medicines (Lange et al., 2001). Estrogenic
EDCs (including estrone, E2, estriol, and EE2) have been shown to enter the aquatic
environment via effluent discharges from sewage treatment works (Sun et al., 2014). The
hormones present in pharmaceuticals (including synthetic estrogens) are not completely
broken down through municipal wastewater sewage treatment plants (Ternes et al.,
1999). The chemical structure of EE2 differs slightly from the chemical structure of the
natural estrogen, E2 (Figure 1.5B), by an additional ethinyl group in EE2; this difference
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leads to changes in biodegradability, making EE2 more resistant to degradation of
microorganisms in wastewater treatment systems (Ternes et al., 1999). As a result,
wastewater effluent from municipal treatment plants discharge EE2 into receiving waters
in both treated and untreated waste waters, and can be found at 0 to 34 ng/L in different
bodies of water (rivers, estuaries, bays, lagoons, surface water, etc) internationally, as
well as in sediments within those bodies of water (Aris et al., 2014; Monteiro and Boxall,
2010). Compounding their reproductive effects, EE2 levels are a concern in aquatic
environments because of EE2’s high resistance to the process of degradation and its
tendency to absorb organic matter, accumulate in sediment and concentrate in biota (Aris
et al., 2014; De Wit et al., 2010). Effluents from municipal wastewater contain mixtures
of various estrogens and their mimics, varying in toxicity (Desbrow et al., 1998). Within
this group of substances, EE2 is one of the more potent synthetic estrogens present, and
has been linked to serious effects on fish development and reproductive status (Desbrow
et al., 1998).

A
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B

Figure 1.5: The chemical structure of the synthetic estrogen, 17α-ethinylestradiol (EE2;
A), and the natural estrogen, 17β-estradiol (E2; B) (Sigma-Aldrich, 2015).

1.4.2 Effects of EE2 on Teleosts
It has been demonstrated that EE2 can negatively impact the reproductive system
and related processes in several teleosts. These effects on the reproductive status and
development of fish can have detrimental long-term effects on fish populations, which
can also impact the ecosystem. Mummichog, however, typically respond at higher
concentrations of EE2 (generally 100 ng/L or higher) compared to the levels (<10 ng/L)
to which other fish respond. For instance, this can be seen when comparing population
and reproductive health effects between commonly-studied freshwater teleosts and
mummichog. EE2 exposure caused intersex (feminization) and induced vitellogenin
(female egg yolk precursor protein) production in fathead minnow at 5-6 ng/L of EE2
during a 7-year whole-lake experiment (Kidd et al., 2007), and in zebrafish when
exposed to 5 ng/L EE2 in a full lifecycle exposure (Nash et al., 2004). Parrott and Blunt
(2005) demonstrated significant effects on fathead minnow fertilization success, sex ratio,
male secondary sex characteristics, GSI (gonadal somatic index), LSI (liver somatic
index) and growth at 0.32-23 ng/L EE2 (nominal), or 0.0-1.5 ng/L of EE2 after RIA
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(radioimmunoassay) detection, 150 days post hatch. In mummichog, reproductive
endpoints do not appear to be affected at similar concentrations of EE2, when compared
to other teleosts. In mummichog, induced male plasma vitellogenin and vitellogenin
mRNA has been demonstrated at higher concentrations of 100 ng/L EE2, after 21-day and
14-day (respectively) exposures (Hogan et al., 2010; Peters et al., 2007). However, EE2treated mummichog larvae showed complete feminization (all treated larvae exhibited
female phenotype) at 10 weeks post hatch, including a low exposure concentration of 10
ng/L (Chehade, 2012), similar to effects in other species.
Reproduction is impacted by EE2 exposure in teleosts, as egg production was
significantly reduced in fathead minnow at concentrations of 0.47-3.92 ng/L after a 21day exposure (Armstrong et al., 2016). Other freshwater species such as Chinese rare
minnow (Gobiocypris rarus) exposed to 0.2 ng/L EE2 (Zha et al., 2008) and zebrafish
exposed to 1 ng/L EE2 (Lin and Janz, 2006) or 25 ng/L for seven days (Schilling, 2015)
exhibited significantly reduced egg production. EE2 does not have such a consistent lowconcentration effect on reproduction in mummichog, as egg production decreased in
females and fertilization decreased in males at only 100 ng/L, as assessed at 28 days
(Peters et al., 2007). A study by Bosker et al. (2016), has further shown that the
cumulative egg production per female was unaffected by high concentrations of EE2 at
100 ng/L (nominal), or 84.1 ng/l ± 6.0 actual, after 28 days of exposure.
EE2’s strong impacts on fish reproduction may be mediated by effect on sex
steroids that regulate reproductive processes. In fish, estrogen mimics compete with
naturally-occurring estrogen for binding to the estrogen receptors and disrupt the
steroidogenic pathway, which can consequently depress plasma hormone levels (Hogan
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et al., 2010). Hormones T, 11-KT and E2 were notably lower in male fathead minnow
after exposure to 10 ng/L EE2 for 21 days (Salierno and Kane, 2009). In mummichog,
some hormones were affected by EE2 at high (e.g., 100 ng/L) concentrations. Female
plasma T and E2 significantly decreased after exposure to EE2 at 100 ng/L for 21 days;
plasma E2 also decreased at 10 ng/L EE2 after 28 days (Peters et al., 2007). Hogan et al.
(2010) demonstrated different effects, as male and female plasma T levels did not differ
significantly among treatments of 100 and 500 ng/L (nominal) of EE2 for 14 days, or 67.9
± 7.4 and 247.9 ± 12 (average) ng/L. Gillio Meina et al. (2013) demonstrated decreases
in female E2 and male 11-KT at 250 ng/L EE2. These data substantiate the general trend
of EE2 effects on mummichog at higher than environmental levels, unlike what has been
found in most other fish species studied.
EDCs have been shown to exert direct effects on gonadal steroidogenesis in
teleosts through various mechanisms (Thomas, 2008). EDCs, such as exogenous
estrogens, may disrupt the steroidogenic pathway by interfering with the gene expression
of specific enzymes at key steps (Hogan et al., 2010). For instance, steroidogenic
enzymes (P450scc, P450c17, and 3β-HSD) expression decreased with EE2 exposure (8
days of oral treatment at 20 mg/kg) in rainbow trout (Baron et al., 2005). In fathead
minnow, steroidogenic enzymes StAR, P450scc and P450c17 were downregulated with
2-50 ng/L EE2; P450arom was not significantly altered, but showed a downward
tendency (Garcia-Reyero et al., 2009). On the other hand, there was no effect on
steroidogenic enzymes StAR, P450scc and P450arom in mummichog ovaries after a 14day exposure to 250 ng/L EE2 (Doyle et al., 2013).
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1.4.3 Potential Mechanisms for High Sensitivity to EE2 in Mummichog
The mechanistic reasons in mummichog for the differences in effects following
EE2 exposure compared to other freshwater teleosts is not known. Previous studies have
tried to determine the factors which cause lower sensitivity in mummichog by focusing
on environmental and physiological variables. Environmental variables that have been
investigated to some extent include salinity, temperature and hypoxia. Salinity was
analyzed as mummichog live in estuarine environments with fluctuating salinity, and
most fish commonly used in EE2 exposure studies are freshwater fish. Salinity increases
EE2 uptake (Blewett et al., 2013), but has no significant effect on plasma steroids or
gonadal steroidogenesis (Gillio Meina et al., 2013). Increased temperature results in
greater EE2 uptake (Blewett et al., 2013). Increased temperature at 26oC, compared to
10oC and 18oC, resulted in increased gonad weight in male and female mummichog and
decreased LSI, yet there was no interaction between temperature and EE2 on either
plasma E2 or T in females, or plasma T and 11-KT in males (Gillio Meina et al., 2013). In
hypoxia, there is little change on the effect on EE2 uptake in mummichog (Blewett et al.,
2013).
Tissue distribution of EE2 accumulation after exposure in mummichog has also
been examined through a comparative study to other species. In mummichog, gallbladder
and liver accumulated the largest amount of radiolabeled EE2 (50%); the carcass and the
gut were the next highest accumulators (Blewett et al., 2014). Alternatively, EE2 was
quickly associated with the carcass (50%) in fathead minnow, goldfish, zebrafish and
rainbow trout (Blewett et al., 2014). This could indicate that EE2 is potentially being
metabolized and cleared more quickly in mummichog compared to other teleosts, thus
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protecting the reproductive system from deleterious effects of EE2. This hypothesis has
not been further investigated and, to date, is the most evidence-based explanation for the
differences in EE2 sensitivity between mummichog and other fish species.
1.5 Objectives
The hypothesis for this thesis is that the differences in E2 regulation during
ovarian development between mummichog and other teleosts may play a part in the
species-specific sensitivity of mummichog to EE2. In most teleosts, the shift between the
developmental stages and maturational stages in oogenesis is accompanied by a shift
from estrogenic (E2) to progestational (MIS) steroid production when follicles progress
from vitellogenesis to a prematurational stage (Nagahama and Yamashita, 2008). These
key steroids, such as E2, T and MIS regulate the ovarian development cycle. E2 is
stimulated by FSH and is produced in correlation with vitellogenesis (involved in
developmental stages); whereas MIS is stimulated by LH and is produced in correlation
with the onset of maturation of oocytes (involved in maturational stages). In mummichog,
however, there is no shift detected as the levels of E2 are consistently high in all stages of
follicles and coexist with high progestagen levels in mummichog (Lin et al., 1987).
Because mummichog have continuously high levels of E2 across maturation, this may
cause a decrease in ovarian sensitivity to EE2, possibly through molecular pathways in
the steroidogenic pathway. EDCs, such as EE2, have been shown to exert direct effects on
gonadal steroidogenesis in teleosts through various mechanisms, and also potentially
alters gonadal steroid production at specific sites within the steroidogenic pathway
(MacLatchy et al., 2003; Hogan et al., 2010; Peters et al., 2007; Thomas, 2008).
Therefore, the present study focused on the molecular characterization of the ovarian
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steroidogenic pathway across the maturational stages in mummichog to firstly, better
understand the molecular changes that occur during steroidogenesis and secondly, the
effects of EE2 in vitro on maturing ovarian follicles.
The approach used was to initially replicate and confirm the current
understanding of mummichog maturation as it relates to ovarian steroidogenesis (e.g.,
changes in plasma and follicular steroids during maturation), and to then add to the body
of knowledge by characterizing for the first time the gene expression changes across the
ovarian development cycle, using in vitro ovarian follicle incubations. With this deeper
mechanistic understanding of mummichog ovarian steroidogenesis, it was then possible
to undertake a preliminary in vitro ovarian follicle exposure across maturational stages to
EE2, to determine the effect on gene expression endpoints known to be estrogen sensitive
in other teleost species. Together, these studies have progressed our understanding of
mummichog ovarian development and provided a potential addition to the mechanistic
understanding of the general resistance of mummichog to environmentally-relevant levels
of EE2.
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2.1 Abstract
This study investigated ovarian development in Fundulus heteroclitus
(mummichog), through molecular characterization of key mediators in the ovarian
steroidogenic pathway; these included ovarian StAR (steroidogenic acute regulatory
protein), cytochrome P450 enzymes, estrogen receptors (ERα, ERβ1 and ERβ2), and
gonadotropin receptors (FSHr and LHr); additionally, hepatic vitellogenin (VTG1) and
ERs, and brain P450 aromatase (P450arom; CYP19b) were studied. Fish were staged into
cortical alveolus, vitellogenic, early mature, late mature, and ovulating stages of
maturation; blood (plasma), ovary (tissue and isolated ovarian follicles per stage), liver,
and brains were collected. Testosterone (T), 17β-estradiol (E2) and maturation inducing
steroid (MIS), measured from plasma and in vitro ovarian follicle incubations, confirmed
that T and E2 production correlate with vitellogenesis and final maturation in
mummichog, whereas MIS correlates with only final maturation in mummichog; no E2,
as is present in other teleosts, drop prior to maturation was observed. The expression of
P450arom (CYP19a1), ERα, StAR, P450 side-chain cleavage, and hepatic VTG1,
determined by qPCR methods, were associated with patterns of E2 in maturing
mummichog, but did not follow patterns exhibited in other teleosts. CYP17 expression
was not associated with E2 patterns in mummichog, or other teleosts. To determine EE2
(17α-ethinyl estradiol) effects during maturation, follicles grouped per stage were
exposed to 50 - 250 nM of EE2 in vitro for 24 hours; there was no effect on P450arom or
LHr expression, or on T or MIS production. The tolerance exhibited by mummichog to
exogenous estrogens in vitro could be partially attributable to continuously high levels of
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E2 present in the maturing ovary, as EE2 during follicular incubations had no effect on
presumed E2-responsive genes.
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2.2 Introduction
In most teleost ovarian development processes studied to date, there is a shift that
occurs from estrogenic (17β-estradiol or E2) to progestational (maturation inducing
steroid or MIS; 17α, 20β-dihydroxy-4-pregnen-3-one) steroid production when follicles
progress from vitellogenesis to a prematurational stage (Nagahama and Yamashita,
2008). E2 is produced in correlation with early developmental stages and rises during
vitellogenesis (the process of vitellogenin synthesis in the liver, under the stimulation of
E2, and uptake into the oocytes; Hoar et al., 1983), whereas MIS is produced in
correlation with the onset of maturation of oocytes (Nagahama and Yamashita, 2008).
MIS role in maturation is to induce resumption of meiosis and germinal vesicle
breakdown (GVBD) in teleost oocytes (Clelland and Peng, 2009; Nagahama and
Yamashita, 2008). In mummichog there is no progestagen shift; the levels of E2 are
consistently higher in all stages of follicles tested and coexist with increasing progestagen
during mummichog (Lin et al., 1987). Similar to other teleosts, MIS continues has a
major role in maturation of mummichog (Petrino et al., 1989).
Ovarian development in teleosts varies from species to species, in both the
duration of the cycle as well as the mechanisms involved in regulating the cycle (Khan
and Thomas, 1999). Selman and Wallace (1986) characterized five stages of oogenesis;
the first stage is the primary growth stage (definitive follicle is formed), the second stage
is the cortical alveolus stage (contains randomly dispersed cortical alveoli, or “yolk
vesicles”), the third stage is vitellogenesis (immense growth of the follicle occurs due to
uptake of vitellogenin), the fourth stage is oocyte maturation, further separated into early
maturation (follicular size increases due to hydration and protein uptake) and late
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maturation (germinal vesicle breakdown occurs), and the fifth stage is ovulation (mature
egg which is ready for ovulation). These stages resemble those as described for other fish
species, including zebrafish (Clelland and Peng, 2009; Lyman-Gingerich and Pelegri,
2007) and rainbow trout (Van Der Hurk and Peute, 1979).
Ovarian development in teleost fish is controlled and regulated by a balance and
interconnectivity among steroids and gonadotropins, through signalling pathways
(Ramezani-Fard et al., 2013). In teleosts like mummichog, gonadotropins FSH (follicle
stimulating hormone) and LH (luteinizing hormone) are released into the bloodstream
from the pituitary and bind to their respective receptors (FSHr and LHr) on the ovary
(Ohkubo et al., 2013; Shimizu et al., 2003). FSH is primarily involved in regulating
gonadal steroidogenesis in the early developmental stages (primary growth – completion
of vitellogenesis), as it correlates with E2 production, whereas LH is primarily involved
in regulating oocyte maturation (early maturation – ovulation), as it correlates with MIS
production (Ohkubo et al., 2013; Swanson et al., 1991). E2 action is mediated by estrogen
receptors (ERs) which have the subtypes ERα (ESR1) and ERβ (including both ERβ1, or
ESR2a, and ERβ2, or ESR2b; Menuet et al., 2002). It is presumed that the gene
expression of ERs is regulated by steroid hormones, so expression rates will fluctuate in
response to changes in steroidogenesis (Thomas, 2008); however, ESR1 is the only
subtype that has been linked to biological function in previous studies, such as
stimulation of vitellogenin synthesis in liver and E2 regulation (Chakraborty et al., 2011).
All sex steroids are derived from cholesterol via a number of enzymatic
conversions in a process known as steroidogenesis (Arukwe, 2008; Leusch and
MacLatchy, 2003). Little is known about the expression of the genes involved in
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regulation of the steroidogenic pathway across ovarian development in mummichog.
These steroidogenic enzymes include: steroidogenic acute regulatory protein (StAR),
which is a sterol transport protein that initiates cholesterol transport into the mitochondria
(Rone et al., 2009); cytochrome P450 side-chain cleavage (P450scc, or CYP11), which
produces pregnenolone (basal steroid) from cholesterol (Young et al., 2005); cytochrome
P450 C17 (P450C17, or CYP17), which can catalyze the hydroxylation of pregnenolone
to yield 17α-hydroxypregnenolone and then dehydroepiandrostone, or the hydroxylation
of progesterone to yield 17α-hydroxyprogesterone and then androstenedione by 3β-HSD
(Young et al., 2005); and cytochrome P450 aromatase (P450arom; CYP19a1 for ovarian,
or CYP19b for brain), which converts T into E2 and is potentially responsible for the drop
in estrogen levels that occur prior to maturation (Young et al., 2005).
EDCs (endocrine disrupting compounds) have been shown to exert direct effects
on gonadal steroidogenesis in teleosts through various mechanisms; EE2 (17α-ethinyl
estradiol; a synthetic estrogen commonly found in municipal waste waters via birth
control and hormone replacement therapy pharmaceuticals) can alter gonadal steroid
production at specific sites within the steroidogenic pathway (Hogan et al., 2010;
Thomas, 2008). EE2 is commonly used as a model compound to study the impact of
estrogenic compounds on aquatic organisms, due to its environmental relevance and
inability to be broken down in municipal wastewater treatment (Bosker et al., 2016).
Mummichog exhibit a greater tolerance to EE2 when compared to other small-bodied
species. For instance, a seven-year whole lake EE2 exposure demonstrated induced
vitellogenin and the feminization of male fathead minnow (Pimephales promelas) at 5-6
ng/L of EE2, and an eventual population collapse. Egg production was significantly
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reduced in fathead minnow at concentrations of 0.47-3.92 ng/L of EE2 after a 21-day
exposure (Armstrong et al., 2016), in Chinese rare minnow (Gobiocypris rarus) and
zebrafish (Danio rerio) at concentrations as low as 0.2 ng/L EE2 and 1 ng/L EE2,
respectively (Lin and Janz, 2006; Zha et al., 2008). Alternatively, mummichog respond to
higher levels of EE2 at concentrations of 100 ng/L (Doyle et al., 2013; Gillio Meina et al.,
2013; Hogan et al., 2010; Peters et al., 2007). Confirming previous studies, Bosker et al.
(2016) demonstrated that cumulative egg production per female was unaffected by high
concentrations of EE2 at 100 ng/L (nominal), or 84.1 ng/l ± 6.0% of nominal, after 28
days of exposure.
Previous studies have tried to determine factors which cause lower sensitivity to
EE2 in mummichog, by investigating environmental and physiological variables. It was
determined that there was no interaction between temperature and EE2, or salinity and
EE2 on plasma steroid levels in mummichog (Gillio Meina et al., 2013). A tissue
distribution study, however, showed that EE2 may be metabolized and cleared more
quickly in mummichog, as mummichog accumulate EE2 to a greater degress in the
gallbladder and liver, compared to the caracass in zebrafish and fathead minnow (Blewett
et al., 2014). Because ovarian physiology differs in mummichog, primarily the lack of an
E2 drop during maturation, it may be at least partially attributable to the decreased
sensitivity of mummichog to EE2.
The objectives of this study were to confirm the current understanding of
mummichog maturation as it relates to ovarian steroidogenesis and to characterize the
gene expression changes across the ovarian development cycle for the first time. With
this deeper mechanistic understanding of mummichog ovarian steroidogenesis, it was
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then possible to undertake a preliminary in vitro ovarian follicle exposure across
maturational stages to EE2, to determine the effect on gene expression endpoints known
to be estrogen sensitive in other teleost species. Together, these studies have progressed
our understanding of mummichog ovarian development and provided a potential addition
to the mechanistic understanding of the general resistance of mummichog to
environmentally-relevant levels of EE2.
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2.3 Materials and Methods
2.3.1 Fish collection and holding
Adult mummichog (6.07 – 21.1 g) were collected in June 2015 from Shemogue
Harbour, NB, Canada (46° 10′ 35″ N, 64° 8′ 55″ W) by seine net (size of mesh: ¼”). The
fish were transported to Wilfrid Laurier University in aerated plastic totes, and
quarantined in 200 L plastic reservoirs for 14 days at room temperature with frequent
water changes before being transferred and maintained in recirculating fish holding units.
Fish were housed in 380 L single stock tanks (Aquabiotech Inc, Coaticook, QC, Canada)
or held in a G-HAB unit consisting of 40 L and 60 L glass aquaria (Pentair, Apopka, FL,
USA). Routine water quality tests (ammonia, nitrite and nitrate levels) and water changes
(25% water change every two weeks and 50% water changes every month) were
conducted to maintain conditions within desired levels. For all holding conditions, the
water was maintained at 16-18 ppt salinity by the addition of artificial sea salt [Crystal
Sea Marine Mix sea salt (Marine Enterprises International, Baltimore, MD, USA)] to
City of Waterloo dechlorinated and reverse osmosis water.
2.3.2 Characterization of the estrogen biosynthetic pathway during ovarian
development
In order to obtain ovaries at different stages during the reproductive cycle,
photoperiod and temperature were adjusted in the stock tanks to mimic seasonal changes.
The temperature and photoperiod began at 4oC and 8 h light: 16 h dark (held at these
conditions for two weeks) to simulate a colder season and obtain regressed stages of
ovarian follicles. The females were also separated from the males during this period and
were fed commercial trout pellets (2mm; EWOS Pacific, Vancouver, BC, Canada) once a
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day. Once sampling was complete (December 2015), the temperature and photoperiod
was slowly raised to 12oC and 12 h light: 12 h dark (temperature was increased 1oC each
day) to simulate warmer seasons and stimulate ovarian recrudescence and maturation.
Males were added to the stock tanks and fish were fed commercial trout pellets twice a
day; the temperature was also further increased slowly to 16oC. Once sampling was
complete for the vitellogenic stage (April 2016), the temperature and photoperiod was
slowly raised to 22oC and 16 h light: 8 h dark (spawning conditions) and fish were fed
commercial trout pellets twice a day, and supplemented with freeze-dried blood worms
(Glycera dibranchiata; BrineShrimpDirect, Ogden, UT, USA) once every other day.
Maturing stages were easily collected at these conditions (April-May 2016).
i)

Sampling
When female mummichog reached desired stages of ovarian development (as

estimated from the increased size and softness of the female abdomen as it becomes
larger with increasing ovarian development), fish were anaesthetized with ~0.05% ethyl
3-aminobenzoate methanesulfonate salt (Sigma-Aldrich, Oakville, ON, Canada), bled
from the caudal vasculature using heparinized 25 G 5/8 needles on 1 mL syringes, and
killed by spinal severance after being weighed, as simplified in Figure S2.4. Fish were
sampled on these dates: December 1st, 2015; April 12th, 15th and 20th, 2016; May 3rd,
2016. The stage of ovarian development was classified with gross morphological
assessment of the ovary following criteria listed in Table 2.1; the dominantly present
stage (dominant stage ~ >75% of follicles in ovary) in samples were verified with
histological assessment. Collected blood was kept on ice then centrifuged at 8000 x g for
10 minutes at 4oC to isolate plasma. Plasma was pipetted and stored at -20oC in 1.5 mL
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centrifuge tubes (Fisher Scientific, Ottawa, ON). E2, T and MIS levels were measured
from plasma samples obtained from 15, 12, 16, 14, and 4 fish respectively classified as
having ovaries with stage 1-5 follicles dominantly present.
The ovary, liver, and brain (pituitaries were not isolated because of difficulty due
to size) were dissected and removed, and ovary and liver were weighed. The ovary and
liver weights, along with the whole-body weight, were used to calculate the GSI (gonadal
somatic index) and LSI (liver somatic index) of each fish.
GSI =

𝑜𝑣𝑎𝑟𝑦 𝑤𝑒𝑖𝑔ℎ𝑡
𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡

x 100

LSI =

𝑙𝑖𝑣𝑒𝑟 𝑤𝑒𝑖𝑔ℎ𝑡
𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡

x 100

The liver and brain were snap-frozen on dry ice, then stored at -80oC, to be used
later for RNA extractions and molecular analysis. The ovary was divided into two
sections: one section was snap-frozen on dry ice and stored at -80oC (utilized later for
RNA extractions and molecular analysis) and another section was placed in 75%
Leibovitz-15 (L-15) medium [L-15 powder with L-glutamine (Sigma-Aldrich) diluted
with ultrapure water as per manufacturer’s instructions; medium was balanced to a pH of
7.5 and contained 10 mL of penicillin streptomycin (Thermo Fisher Scientific,
Burlington, ON, Canada)]. Gene expression was measured from ovary (tissue), liver
(tissue) and brain (whole) samples obtained from 9-12, 10-11, 14-15, 14, and 4 fish
classified as having ovaries with stage 1-5, respectively, follicles dominantly present.
ii)

In vitro methodology
Whole ovary tissue was placed into glass petri dishes containing 75% L-15

medium and gently teased apart using forceps to separate different stages of follicles. In
order to classify follicles into stages, an EVOS XL digital inverted microscope imaging
system (Life Technologies, Thermo Fisher Scientific) was used to identify morphological
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characteristics and measure follicle diameter, which corresponded to criteria in Table 2.1.
Example images of staged follicles are shown in Figure 2.1. The incubation protocol was
modified from McMaster et al. (1995) and MacLatchy et al. (2003). Follicles grouped by
stage were incubated in 1 mL (stages 1-3) or 2 mL (stages 4-5) of culture medium (75%
L-15) for 24 hours at 18oC, as simplified in Figure S2.6A. Each well contained 24 mg of
tissue (3 pieces of 7-8 mg) for stage 1 (cortical alveoli) ovaries or 15 follicles for stage 25 follicles, from individual fish. Samples from each fish were distributed into 2-6 wells,
depending on the available tissue or follicles. The wells were divided into two treatments:
control [basal (medium only)] or hCG (human chorionic gonadotropin; Lee Biosolutions,
Maryland Heights, MO, USA) treated at 20 IU/mL. Preliminary results showed that this
concentration of hCG stimulated steroid production by follicles (data not shown) and has
been used in other studies (MacLatchy et al., 2003). hCG is an analogue to LH
(luteinizing hormone), an endogenous gonadotropin responsible for oocyte maturation
and stimulation of steroidogenesis. After incubation, medium was removed and stored at
-20oC, while tissue was removed and stored at -80oC. The medium was later used for
steroid hormone measurement of E2, T and MIS through enzyme immunoassay (EIA)
analysis; medium was obtained from 10, 15, 12, 16, and 10 fish for stages 1-5,
respectively.
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Table 2.1. Size and morphology classification of ovarian stages (Modified from Selman
and Wallace, 1986), verified through examination under an EVOS XL digital inverted
microscope.
Stage of
Stage of
Follicle
Fish
(R)
(1)
Regressed
Cortical
Alveolus
(V)
(2)
Vitellogenesis Vitellogenic
(3)
Early
Maturation
(4)
Late
Maturation
(5)
Ovulated

Follicle
Diameter
175-550 µm

550-1350
µm

(EM) Early
Mature

1350-1700
µm

(FM) Fully
Mature

1700-1900
µm

(OV)
Ovulated

1900 µm +

Description
Appearance of cortical alveoli (“yolk
vesicles”)
Ooplasm is opaque, membrane-bound
yolk spheres occur & germinal vesicle
visible under microscope
Ooplasm becomes more translucent as
oocyte matures & several oil droplets
appear (dispersed)
Ooplasm becomes more transparent,
Germinal vesicle breakdown, lipid
droplets continue to coalesce
Transparent follicles with no apparent
membrane, covered by coat material
“jelly” & oil droplets migrate to one pole
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Figure 2.1. Images of staged follicles across the ovarian development cycle in
mummichog: (A) cortical alveolus, (B) vitellogenesis, (C) early-mid mature, (D) late
mature, (E) ovulated. Scale bar is 2000 µm for images A-C and E; scale bar is 1000 µm
for image D. CAF = cortical alveolus follicle; GV = germinal vesicle; LD = lipid
droplets. Images obtained from the EVOS XL digital inverted microscope imaging
system.

iii)

Measurement of steroid hormone levels by EIA
Steroids were extracted from plasma samples using ethyl-ether (according to

Gillio-Meina et al., 2013). The extracted samples were dried overnight at room
temperature and then reconstituted in 500 µL of EIA buffer (Cayman Chemical, Ann
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Arbor, MI, USA) and stored at -80°C. Media samples from the in vitro incubations were
assayed without extraction. EIAs for E2, T, and MIS were conducted as per the
manufacturer’s (Cayman Chemical) instructions. The appropriate dilution for each steroid
stage and basal or stimulated treatment, was determined by analyzing serial dilutions of
pooled samples; dilutions used on plasma or media samples were either 2x or 4x. To
determine if there was interference in the EIA caused by the L-15 media samples,
standard curves were generated with both L-15 medium and EIA buffer; no differences
were found. Therefore, media samples were assayed directly in the EIA. Interassays were
created for each hormone measured; following EIA, the coefficient of variation was
calculated to be 7% for E2, 13% for T, and 11% for MIS [standard deviation of
samples/mean of samples x 100], which indicates that the method is reproducible and
reliable. The samples were read at a wavelength of 420 nm using a Molecular Device
SpectramaxPlus 384 microplate reader (Molecular Devices, Sunnyvale, CA, USA). Mean
fold increase (shown to compare hCG-stimulated production to basal production, per
treatment and stage) was calculated as follows:
(ℎ𝐶𝐺 𝑣𝑎𝑙𝑢𝑒⁄𝑏𝑎𝑠𝑎𝑙 𝑣𝑎𝑙𝑢𝑒) of sample 1 + (ℎ𝐶𝐺 𝑣𝑎𝑙𝑢𝑒⁄𝑏𝑎𝑠𝑎𝑙 𝑣𝑎𝑙𝑢𝑒) sample of 2 … + (ℎ𝐶𝐺 𝑣𝑎𝑙𝑢𝑒⁄𝑏𝑎𝑠𝑎𝑙 𝑣𝑎𝑙𝑢𝑒) of sample N
𝑁

iv)

RNA extraction, cDNA synthesis and qPCR
Total RNA was extracted from frozen ovary (whole ovary or isolated follicles),

liver and brain tissue, using TRIzol reagent (Invitrogen, Burlington, ON, Canada). The
protocol was carried out as per the manufacturer’s instructions with minor modifications.
Ovary and liver samples (20-50 mg), whole brains, or separated follicles (15-40,
depending on experiment) were added to centrifuge tubes with 800 µL of TRIzol reagent,
and homogenized via mechanical disruption using a hand-held homogenizer (Knotes
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Pellet Pestle Cordless Motor, Fisher Scientific), or a 21G (0.8 mm x 25 mm) needle on a
3 mL syringe. Chloroform (160 µL) was added for the extraction of RNA into the top,
clear supernatant. The samples were centrifuged at 12,000 x g for 15 minutes at 4oC, after
which the top RNA layer was decanted into 400 µL of iso-propanol of a correspondingly
labelled tube, and then centrifuged again at the same parameters. The supernatant was
discarded, and 800 µL of 75% ethanol was added to the tubes containing the RNA pellet,
then the tubes were centrifuged at 7,500 x g for 5 minutes at 4oC. The ethanol layer was
poured off and the pelleted RNA was dissolved in 10-60 µL (depending on size of pellet)
of RNase-free water. The samples were then vortexed briefly, heated at 55-58oC for 5-10
minutes to fully dissolve the RNA pellet, and stored at -80oC.
RNA yield was verified using a Nanodrop 8000 (Thermo Fisher Scientific,
Burlington, ON) with 2 µL of samples at two dilutions of 10 and 50x to allow for an
accurate calculation of the undiluted RNA. RNA samples were then diluted to 1000
ng/µL with molecular grade water, for use in the cDNA reactions. RNA sample quality
was checked at a 260/280 nm wavelength, and samples were read between 1.6 and 2.0. A
subset of 10x diluted RNA samples were randomly selected from each experiment to
verify RNA integrity using RNA StdSens Chips on the Experion Automated
Electrophoresis Station (Bio-Rad Laboratories, Mississauga, ON, Canada) as per the
manufacturer’s instructions.
RNA samples were treated for potential genomic DNA contamination with the
AMP-D1 kit (Sigma Aldrich) according to the instructions prior to cDNA synthesis. 2 µL
of 1000 ng/µL RNA was added to a 0.2 mL PCR tube containing 6 µL of RNase-free
water, 1 µL of 10 x Reaction Buffer and 1 µL of DNAse enzyme. The samples were
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heated at 70oC for 10 minutes [using a C1000 PCR thermocycler (Bio-Rad Laboratories)]
and then chilled on ice. Reverse transcription of total RNA was performed with 4 µL of
iScript Reverse Transcription Supermix (Bio-Rad Laboratories) and followed the
manufacturer’s instructions, with parameters of 5 min at 25oC for priming, 30 min at
42oC for RT (reverse transcription), 5 min at 85oC for inactivation, and cooling to 4oC.
The resulting cDNA was stored at -20oC until real-time quantitative PCR (qPCR)
analysis.
qPCR was performed in duplicate for each sample using SsoFast EvaGreen
Supermix and the CFX96 Real-Time System (Bio-Rad Laboratories) in a reaction
volume of 10 µL containing 2.5 µL of cDNA, 5 µL EvaGreen, 1.25 µL of each forward
and reverse primers. The qPCR parameters were 30 seconds at 95oC, followed by 40
cycles of 95oC for 1 second and 55oC for 5 seconds, which was the annealing temperature
determined to be best suited for all of the primers through a series of temperature gradient
tests. To demonstrate primer specificity and the amplification of a single amplicon,
dissociation curves were conducted on all reactions. Genomic DNA and RT-water
controls were conducted on approximately 10% of the samples and were found to be free
of contamination.
Oligonucleotide primers for most genes of interest were designed using IDT
PrimerQuest Tool, and obtained from either Sigma-Aldrich or IDT [Integrated DNA
Technologies (Coralville, IA, USA)]. Table 2.2 presents the primer sequences and their
NCBI GenBank accession numbers. The relative standard curve qPCR method was used
and six-point standard curves were generated for each gene with primer efficiency values
shown in Supplementary Table S2.1.
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Genes of interest were normalized to a reference gene, which was shown to not
change expression levels in female mummichog undergoing ovarian development (data
shown in Figure S2.1, S2.2, and S2.3). The reference genes used were estrogen receptor
β1 (ESR2a) in the ovary, 18sRNA in the liver, and EF1α in the brain.

Table 2.2. Forward (FWD) and reverse (REV) primer sequences used for qPCR analysis
with accession numbers and commercial source.
Gene
Β-Actin
EF1α
18s-RNA
ESR1
ESR2a
ESR2b
LHr
FSHr
StAR
CYP11a1
CYP17a1

CYP19a1
CYP19b
Vtg1

FWD
REV
FWD
REV
FWD
REV
FWD
REV
FWD
REV
FWD
REV
FWD
REV
FWD
REV
FWD
REV
FWD
REV
FWD
REV

Sequence 5’-3’
GCA CGG TAT TGT GAC CAA
GGG TGT TGA AGG TCT CAA
TCA CCA TCA GCT TTT ATA AAG
GAC GCT CCA TTG CCT ACT GTC
GTC GTA GTT CCG ACC ATA AAC
CAC CCA CAG AAT CGA GAA AG
ACT CTA CCA CTG GCT ACT ACT C
GCT GGT GAC TGG ATC TGT AAA
GAG GAG CAT CCA AGG ACA TAA C
TTG GTC ATG CCG ACT TCA TAG
CTC AGC CGA ACC ACA GTA ATC
CTC CAG CCA GCA ACA CTT TA
TGG AAA CCA TCG AGG CAT TAG
GAC ATC AGG GAA GAG CGT TAT C
CCA TCT CCT TCT TTG CCA TCT
CCA TCC AGA CTC AGC GTA TTC
CCT TCA AAA GAT CGG ACA GG
TTT CTG AGG CAT TTG TG
TTC AAG GCA GAG GGT CAA TAT C
AGG TCC GTG GTC CAT TTA TTC
CTG CTT CAA CTC CTC CTA TTC
CCT TGT GCT CGT TGT ACT T

FWD
REV
FWD
REV
FWD
REV

GTC CAC TCT TGT CTT ATT TG
GTC TCC TCT CCA TTG ATC
CTG TGA GGA CTC AGA AA
TCA GTG CGA GGT TAT AC
GTT GGC ATA CAC TGA GAA
AGA CGT AAC TTA ATG TTG TG

Accession #
AF397164

Company
Sigma

AY735180

Sigma

M91180

IDT

AY571785

IDT

AY570922

IDT

AY570923

IDT

AB295491

IDT

AB295490

IDT

Doyle et al.,
2013
AB471800

IDT

XM_012852
073
(Predicted
Sequence)
AY428665

IDT

Sigma

AY428666

IDT

AAA93123

Sigma

IDT
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v)

Histological assessment
At the time of dissection and based on gross morphology, ovaries were classified

according to Table 2.1 if approximately ≥75% of the follicles present within the ovary
appeared to be in the desired stage (1 – 5). Histological assessments of approximately
25% (N= 3-4 per stage) of the ovaries were conducted to ensure the ovaries contained a
majority of the desired stage of follicle (Figure 2.2). Follicle diameter was measured with
the EVOS XL digital inverted microscope imagining system (Figure 2.1). Histological
assessments of subsamples of the ovaries verified these classifications (Figure 2.2).
Pieces of whole ovary were placed into cassettes [7x12 mm Tissue Path MACROSETTE
Processing/Embedding Cassettes (Fisher Scientific)], immersed in 10% buffered formalin
(Fisher Chemical, Ottawa, ON, Canada) and processed by the University of Guelph
Animal Health Laboratory. Samples were paraffin embedded, cross-sectioned at 4 µm at
3 different levels, stained with standard haemotoxylin and eosin, and mounted on slides
using Tissue Tek permanent mounting medium (Sakura Finetek, Torrance, CA, USA).
Slides were examined under a Zeiss Axio Upright Observer Microscope (Carl Zeiss,
Toronto, ON) under 5-10x magnification, using ZEN Pro Software (Carl Zeiss, Toronto,
ON) to determine the stage of ovarian development and to allow for measurements of the
diameters of the follicles as shown in Table 2.1.
2.3.3 Molecular characterization of the biosynthetic pathway of ovarian follicles
In order to characterize the expression of genes across follicular stages of
development and provide a comparison of the expression levels determined in whole
ovarian tissue, individual follicles were separated and classified by stage. The females
used for this work were held at conditions known to be favourable for the continuous
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production of mature eggs (spawning conditions: 22oC with 16h L: 18h D, as per
demonstrated in Peterson et al., 2010). The fish were from the same stock used in the
work described in Section 2.3.2, but were sampled on February 10th and 17th 2017, to
collect sufficient numbers of follicles at each stage from multiple fish.
i)

Sampling
Sampling was followed as outlined in section 2.3.2.i and ii with few exceptions.

The whole ovary was dissected and placed directly into petri dishes containing 75% L-15
medium, and underwent the sorting process (similar to section 2.3.2.ii). When collecting
ovulated follicles (stage 5), the abdomen of the fish was slightly squeezed to release the
ovulated follicles from the abdominal cavity, through the ovipositor. After sorting, the
isolated follicles were removed from the medium and placed in sterilized 1.5 mL Flat
Top Microtubes (Diamed, Mississauga, ON) in groups of ~30-40 follicles that were snapfrozen and stored at -80oC. The total time for this process was under 10 minutes, as each
fish was processed individually. Gene expression was measured from grouped ovarian
follicle samples obtained from 7-8 fish for each stage.
ii)

RNA extraction and qPCR
The RNA extraction and qPCR protocol was followed as outlined in section

2.3.2.iv with minor modifications. Total RNA was extracted from frozen ovarian follicles
(30-40 per sample), using TRIzol reagent. Following the extraction procedure total RNA
was pelleted, rinsed with 75% ethanol, reconstituted in 10-40 µL RNase-free water and
incubated at 56-59oC for 5-10 minutes to fully dissolve the RNA pellet. Gene expression
values were normalized to adjusted values of ESR2a, based on the approach described by
Ings and Van Der Kraak, 2006 (Table S2.1), due to the inability to find a reference gene
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which was steadily expressed across all stages. Stage 5 (ovulated) follicles produced nondetectable amounts of gene expression, so they were excluded from gene expression
analysis data.
iii)

Histology assessment
The histology protocol was followed as outlined in section 2.3.4.v, with the

exception of storing the isolated follicles in 15mL disposable, polypropylene centrifuge
tubes (Fisher Scientific) containing ~5mL of 10% buffered formalin. These centrifuge
tubes were sent to the University of Guelph Animal Health Laboratory to be processed
for histological analysis.
2.3.4 Effect of EE2 on basal and hCG-stimulated ovarian follicles: steroid
production and gene expression
To assess the effect of EE2 on gene expression and hormone production at the
gonadal level in mummichog, staged ovarian follicles were exposed to 50-250 nM of EE2
over a 24 h incubation period, as simplified in Figure S2.5. The fish used in this
experiment were from the same stock used in the work described in Section 2.3.2 and
2.3.3., but were sampled from October 21st 2016 to December 21st 2016, over 11 days in
order to collect sufficient numbers of follicles at each stage for each treatment, from
multiple fish. Stock tanks were held at spawning conditions (22oC with 16h L: 18h D) in
order to obtain ovaries with follicles at various maturation stages.
i)

Sampling
Sampling was followed as outlined in section 2.3.3.i with minor modifications.

After the sorting process, the separated follicles were removed from the medium and
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placed in 1-2 mL of fresh medium in in vitro plate wells. Wells each contained 25
follicles of a specific stage; the mass of tissue for each well was recorded prior to
incubation. Regressed ovaries (stage 1) were cut into pieces of 7-8 mg, while in medium,
with a total of 3 pieces per well (total ~24 mg).
ii)

In vitro methodology
The in vitro protocol was followed as outlined in 2.3.2ii with a few exceptions, as

simplified in Figure S2.6B. The follicles were obtained from multiple fish for every stage
(3-4 individual fish per pool). Each pool was distributed into 11 wells. Each well
contained 24 mg of tissue (three pieces of 7-8 mg) for regressed (cortical alveoli) ovaries
or 25 follicles for vitellogenic to ovulated ovaries. There were 11 treatments per stage,
with a total of 7-8 reps per stage (n = 7-8). The first treatment was time zero; after
follicles were sorted, samples from each pool were removed from the medium and
directly snap-frozen, then stored at -80oC. There were five treatments: no solvent control
(only L-15 medium), solvent (ethanol) control, 50 nM EE2, 100 nM EE2, and 250 nM
EE2; these treatments were either basal or hCG-stimulated, resulting in a total of 10
treatments plus one time zero sample per pool/stage. Concentrated stocks of EE2 (SigmaAldrich) were prepared in ethanol at concentrations of 10, 20, and 50 µM, and stored in
glass vials at -20oC. EE2 and ethanol were added to wells at 5 µL per 1 mL of total
solution (as per McMaster et al., 2005), resulting in final concentrations of 50, 100 and
250 nM per well (concentrations are equivalent to 14.82 µg/mL, 29.64 µg/mL, and 74.1
µg/mL respectively). After incubation, the media were removed, stored at -20oC, and
used later for steroid hormone measurement of T and MIS through EIA analysis, on a
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subset of samples (all stage 2, 3 and 4 samples). The tissue was also removed, stored at 80oC and later used for gene expression analysis.
iii)

RNA extraction and qPCR
The RNA extraction and qPCR protocol were followed as outlined in section

2.3.3.ii with the exception that total RNA was extracted from frozen ovarian follicles (25
per sample), using TRIzol reagent. Gene expression values were normalized to β-actin.
2.3.5 Statistics
Statistical analysis was performed using SPSS 23 (IBM Canada Ltd, Markham,
ON, Canada). One-way analysis of variance (ANOVA) was performed to assess plasma
and in vitro steroid hormone levels (E2, T & MIS), or gene expression (ERs, P450
enzymes, StAR, LHr, FSHr), across the different stages of maturation. Two-way
ANOVA was performed to assess basal T and MIS production across different stages of
follicle maturation with different treatments of EE2 (from in vitro exposure).
Assumptions of normality and homogeneity of variance were tested using Shaprio-Wilk’s
W test and Levene’s test, respectively. If the data were not normally distributed, or did
not test positive for homogeneity of variance, the data were log transformed or squareroot transformed (rarely) through SPSS, and the parameters were tested again. If the
normality and variance tests still failed after data transformation, then the non-parametric
Games-Howell test was used; Tukey’s test was used for all parametric post hoc analyses.
In all cases, a p-value of 0.05 was chosen to indicate significance.
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2.4 Results
2.4.1 Characterization of the estrogen biosynthetic pathway during ovarian
development
i)

Morphometric Data
Morphometric data, such as body weight, gonad weight and liver weight, were

recorded from sampled fish and analyzed to determine the mean GSI and LSI for each
stage of fish. Mean GSI in fish increased with increasing stage of ovarian development
[minimum at R, 1.72 ± 0.17 %; maximum at OV, 12.36 ± 3.2 %; p = 0.00 (Table 2.3)], as
did body weight [minimum at R, 10.1 ± 0.55 g; maximum at OV, 17.4 ± 1.0 g; p = 0.00
(Table 2.3)], and gonad weight [minimum at R, 0.17 ± 0.01 g; maximum at OV, 2.09 ±
0.45 g; p = 0.00 (Table 2.3)]. Mean LSI in fish remained relatively the same across
stages, except for an increase in regressed fish [minimum at FM, 3.87 ± 0.32 %;
maximum at R, 6.53 ± 0.24 %; p = 0.00 (Table 2.3)], and there were no significant
changes in liver weight across stages [minimum at V, 0.55 ± 0.05 g; maximum at OV,
0.80 ± 0.11 g; p = 0.20 (Table 2.3)].
ii)

Plasma hormones in females across the reproductive cycle
Plasma E2 production was highest compared to T or MIS levels across all stages

of fish examined (Figure 2.3). R (regressed) refers to fish containing primarily cortical
alveoli follicles; V (vitellogenic) refers to fish containing primarily vitellogenic follicles;
EM (early mature) refers to fish containing primarily early mature follicles; FM (fully
mature) refers to fish containing primarily late mature follicles; OV (ovulated) refers to
fish containing primarily ovulated follicles. Plasma T levels increased from regressed to
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fully mature fish and were highest in fully mature fish; fully mature fish were
significantly higher than regressed or vitellogenic fish [minimum at V, 88.5 ± 21.3
pg/mL; maximum at FM, 250.0 ± 32.0 pg/mL; p = 0.00 (Figure 2.3 A)]. Mean plasma E2
significantly increased from regressed to fully mature fish, and dropped in ovulating fish
[minimum at R, 26.5 ± 3.09 pg/mL; maximum at FM, 2550 ± 339 pg/mL; p = 0.00
(Figure 2.3 B)]. Mean plasma MIS had no significant changes from regressed to early
mature fish, but significantly increased form early mature to ovulating fish [minimum at
V, 0.3 ± 0.1 pg/mL; maximum at OV, 5.0 ± 1.2 pg/mL; p = 0.00 (Figure 2.3 C)].
iii)

In vitro steroid production across follicular stages of ovarian development
Basal E2 production was highest compared to T or MIS levels across all stages of

follicles examined (Figure 2.4). Mean basal and hCG-stimulated levels of E2, T and MIS
(Figure 2.4) dropped between stages 1-2. The decline in basal in vitro hormone
production seen in stage 2 follicles is most likely due to the difference in tissue weight
per well (a methodological issue), and the results are focussed on stage 2 to stage 5
follicles. Basal T significantly increased during stage 4, while having no significant
differences across stages 2, 3 or 5 [minimum at stage 3, 10.2 ± 1.5 pg/mL; maximum at
stage 4, 26.5 ± 5.0 pg/mL; p = 0.00 (Figure 2.4 A)]. Basal E2 increased from stage 2 to
stage 4 [minimum at stage 5, 84.7 ± 25.7 pg/mL; maximum at stage 4, 2096 ± 261
pg/mL; p = 0.00 (Figure 2.4 C)]. Basal MIS levels significantly increased from stage 2 to
stage 4, and remained at high levels during stage 5 [minimum at stage 2, 0.96 ± 0.2
pg/mL; maximum at stage 5, 18.45 ± 7.8 pg/mL; p = 0.00 (Figure 2.4 E)]. hCGstimulated T, E2 and MIS production was highest at stage 3, had no significant
differences between stages 3-4, and had low production during stage 2 and 5 (p = 0.00 for
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each hormone; Figure 2.4 B, D, F). hCG-stimulated hormone production was highest for
E2, then MIS, and lowest for T.
Fold increase of hCG-stimulated to basal production of steroids by separated and
staged (stages 1 to 5; refer to Table 2.1) follicles were examined to compare hormone
levels across different stages of maturation, without being influenced by follicle size or
weight. Early mature (stage 3) follicles showed the greatest capacity to respond to hCG
treatment and the MIS response seemed most pronounced at this stage given that hCG
had little stimulatory effect on MIS at all other stages (Figure 2.5). The fold increase
(hCG-treated to basal hormone levels) of T, E2 and MIS at stage 3 were 25.8 ± 6.9 [p =
0.00 (Figure 2.5 A)], 5.0 ± 0.8 [p = 0.00 (Figure 2.5 B)], and 243.2 ± 66.7 [p = 0.00
(Figure 2.5 C)], respectively.
iv)

Gene expression in females across the reproductive cycle
Gene expression was determined in whole ovary pieces from fish that were

sampled over the reproductive cycle having group-synchronous ovaries, characterized as
containing >75% of a desired stage (based under gross examination under a microscope).
Follicles were later verified through histological assessment (Figure 2.2) and stage of fish
was supported with morphometric data (Table 2.3). Ovarian expression data were
normalized to estrogen receptor ERβ1 (ESR2a) and displayed as the fold change relative
to the regressed stage. The constant expression of ESR2a across all ovarian
developmental stages is shown in Supplemental Figure S2.1.
Ovarian expression of ESR1 significantly increased in vitellogenic fish and had
no significant changes in expression throughout the rest of maturation [minimum at R,
1.0 ± 0.2; maximum at FM, 4.8 ± 0.5; p = 0.00 (Figure 2.6 A)]. Ovarian ESR2b
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expression peaked in regressed fish, dropped in vitellogenic fish and had no significant
differences in expression throughout the rest of maturation [minimum at OV, 0.2 ± 0.1;
maximum at R, 1.0 ± 0.3; p = 0.00 (Figure 2.6 B)]. Expression of FSHr in ovary peaked
in early mature fish and had no significant differences between early maturation to
ovulation [minimum at R, 1.0 ± 0.2; maximum at EM, 8.9 ± 2.5; p = 0.00 (Figure 2.6 C)].
Ovarian expression of LHr increased from regressed to fully mature fish, and decreased
in ovulating fish [minimum at R, 1.0 ± 0.3; maximum at FM, 56.6 ± 15.7; p = 0.00
(Figure 2.6 D)].
All steroidogenic enzymes increased in expression throughout the ovarian
development cycle. StAR expression was highest in ovulating fish [minimum at R, 1.0 ±
0.1; maximum at OV, 184.1 ± 92.9; p = 0.00 (Figure 2.7 A)]. CYP11 expression was
highest in fully mature fish [minimum at R, 1.0 ± 0.1; maximum at FM, 21.4 ± 6.8; p =
0.00 (Figure 2.7 B)]. CYP17 expression was highest in fully mature and ovulating fish
[minimum at V, 0.7 ± 0.1; maximum at OV, 4.3 ± 1.3; p = 0.002 (Figure 2.7 C)].
CYP19a1 peaked in fully mature fish [minimum at V, 0.7 ± 0.2; maximum at FM, 6.2 ±
3.0; p = 0.00 (Figure 2.7 D)].
Liver gene expression was analyzed from whole liver tissue dissected from fish
that were sampled over the reproductive cycle having ovaries characterized as containing
>75% of a desired stage. Liver expression data were normalized to 18sRNA and
displayed as the fold change relative to the regressed stage. The constant expression of
18sRNA across all ovarian developmental stages is shown in Supplemental Figure S2.2.
Expression of ESR1 in the liver increased throughout the cycle, and was highest
in ovulating fish [minimum at R, 1.0 ± 0.1; maximum at OV, 2.5 ± 0.4; p = 0.00 (Figure
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2.8 A)]. VTG1 expression is associated with ESR1 expression trends [minimum at R, 1.0
± 0.2; maximum at OV, 26.8 ± 1.8; p = 0.00 (Figure 2.8 D)]. Expression of ESR2a
decreased throughout the cycle, with no significant changes between early maturation to
ovulation [minimum at FM, 0.2 ± 0.0; maximum at R, 1 ± 0.1; p = 0.00 (Figure 2.8 B)].
Expression of ESR2b peaked at in vitellogenic fish, with low expression and no
significant changes in all other stages [minimum at R, 1.0 ± 0.13; maximum at V, 11.1 ±
1.8; p = 0.00 (Figure 2.8 B)].
Brain gene expression was analyzed from whole brain tissue dissected from fish
that were sampled over the reproductive cycle having ovaries characterized as containing
>75% of a desired stage. Brian expression data were normalized to EF1α and displayed
as the fold change relative to the regressed stage. The constant expression of EF1α across
all ovarian developmental stages is shown in Supplemental Figure S2.3. There were no
significant changes in expression of CYP19b across the ovarian development cycle
[minimum at OV, 0.8 ± 0.3; maximum at V, 1.2 ± 0.1; p = 0.61 (Supplemental Figure
S2.4)].
2.4.2 Molecular Characterization across Follicular Stages in the Maturation Cycle
Using additional fish, gene expression in follicles isolated by 100% stage were
assessed. Gene expression in stages 1-5 (refer to Table 2.1) were measured and verified
through histological analysis. Stage 5 (ovulating) was excluded as qPCR results showed
non-detectable expression (with the exception of ESR2b). Follicular expression data were
normalized to adjusted values of ESR2a and displayed as the fold change relative to stage
1. The formula used for adjusting ESR2a values is found in Supplementary Table S2.1.
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Follicular expression of ESR1 had no significant differences amongst stages 1-3;
however, stage 4 (late mature) was significantly lower than stage 2 (vitellogenic)
[minimum at stage 4, 0.7 ± 0.1; maximum at stage 2, 1.6 ± 0.1; p = 0.00 (Figure 2.9 A)].
Expression of ESR2b decreased across maturation [minimum at stage 5 (ovulated), 0.0 ±
0.0; maximum at stage 1 (cortical alveoli), 1 ± 0.3; p = 0.00 (Figure 2.9 B)]. FSHr
expression peaked during stage 2, and had low expression with no significant differences
across all other stages [minimum at stage 4, 0.7 ± 0.3; maximum at stage 2, 6.4 ± 0.7; p =
0.00 (Figure 2.9 C)]. LHr expression increased across maturation until stage 3 (early
mature) [minimum at stage 1, 1 ± 0.3; maximum at stage 4, 19.0 ± 2.1; p = 0.00 (Figure
2.9 D)].
Follicular expression of StAR and CYP11 increased throughout the cycle. StAR
had highest expression during stage 4 (late mature) [minimum at stage 1, 1 ± 0.09;
maximum at stage 4, 171.5 ± 76.0; p = 0.00 (Figure 2.10 A)], and CYP11 peaked during
stage 3 (early mature) [minimum at stage 1, 0.9 ± 0.2; maximum at stage 3, 6.1 ± 1.4; p =
0.00 (Figure 2.10 B)]. Expression of CYP17 peaked during stage 1 (cortical alveoli) and
had minimal expression across stages 2-4 (vitellogenic – late mature) [minimum at stage
3, 0.0 ± 0.0; maximum at stage 1, 1 ± 0.2; p = 0.00 (Figure 2.10 C)]. There were no
significant changes in expression of CYP19a1 between stages 1-3 (cortical alveoli – early
mature); however, there was a significant decrease in expression at stage 4 (late mature)
[minimum at stage 4, 0.2 ± 0.1; maximum at stage 2, 1.3 ± 0.2; p = 0.00 (Figure 2.10 D)].
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2.4.3 Effect of EE2 on Basal and hCG-stimulated Follicular Steroid Production and
Gene Expression
Gene expression in follicles (stages 1-4; cortical alveoli, vitellogenic, early
mature, and late mature) isolated by stage (e.g., stage 2 contained 100% follicles at stage
2) were assessed after in vitro incubation with varying EE2 treatments. The medium was
removed and utilized for hormone analysis and the tissue was utilized for gene expression
analysis. The basal and hCG-stimulated steroid results of the in vitro incubations from
ovarian follicles (stages 2-4), treated with 50, 100 and 250 nM EE2 are shown in Table
2.4. As expected, basal T and MIS levels increased significantly with increased
maturational stage of the ovarian follicles [for T, p = 0.00 from Two-way ANOVA; for
MIS p = 0.00 from Two-way ANOVA (Table 2.4)]; however, the steroid levels were
unaffected by EE2 treatments (50, 100 and 250 nM) at all stages examined. There was no
significant effect of EE2 on basal T levels (for stages 2-4, p = 0.11, 0.09, and 0.67,
respectively (Table 2.4)) or hCG-stimulated T levels (for stages 2-4, p = 0.51, 0.36, and
0.57, respectively (Table 2.4)) for any stage of maturation analyzed. There was no
significant effect of EE2 on basal MIS levels (for stages 2-4, p = 0.88, 0.26, and 0.97
(Table 2.4)) or hCG-stimulated MIS levels (for stages 2-4, p = 0.44, 0.69, 0.98,
respectively (Table 2.4)) for any stage of maturation analyzed. hCG-stimulated
incubations produced significantly higher levels of hormone for both T and MIS during
stages 2-4 (p < 0.05; data not shown).
Follicular expression data were normalized to β-actin, and displayed as the fold
change relative to the time 0-hour control. There were no significant effects of EE2
treatment on CYP19a1 expression for any stage of follicular development (Table 2.5).
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There was a significant increase in CYP19a1 expression with hCG stimulation for stages
2, 3 and 4 (for stages 1-4, p = 0.00, 0.03, 0.00, 0.00). Time 0 expression was greater than
basal 24 h expression for all stages, but varied per stage for hCG-stimulated expression.
Stage 1: time 0 > 24h expression, stage 2: time 0 = hCG-stimulated 24 h expression,
stage 3 and 4: time 0 < hCG-stimulated 24 h expression. There was no significant effect
of EE2 treatment on LHr (luteinizing hormone) expression for any stage of follicular
development as well (Table 2.5). hCG stimulation had no effect on LHr expression for
either stage (for stages 1-4, p = 0.21, 0.71, 0.09, 0.43). Time 0 expression was equal to 24
h expression levels for stages 1-4, however the basal control was significantly lower than
time 0 expression at stage 3.
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Figure 2.2 Images of ovarian tissue sampled from mummichog over the developmental
cycle to provide examples of the ovaries staged as A) regressed (primarily stage 1), B)
vitellogenic (primarily stage 2), C) early mature (primarily stage 3), D) fully mature
(primarily stage 4), E) ovulated (primarily stage 5). Scale bar is 200 µm. PN =
perinucleolar; CA = cortical alveolar; GV = germinal vesicle; PV = previtellogenic; V =
vitellogenic; YP = yolk proteins; EM = early mature; M = mature; PO = post ovulated;
JC = jelly coat. H&E stained sections were prepared by the University of Guelph
Histology Laboratory.
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Table 2.3. Mean (± SEM) body weight, gonad weight, liver weight, gonadosomatic and liversomatic index of female mummichog
sampled with ovaries containing a majority of cortical alveoli (regressed), vitellogenic, early mature, late mature (fully mature) or
ovulated follicles. Different letters indicate significant differences for the GSI and LSI. P = 0.00 for body weight, gonad weight, GSI
and LSI. P = 0.198 for liver weight.
Sample Date

Stage

Gonad Weight
(g)
0.17 ± 0.01 A

Liver Weight
(g)
0.65 ± 0.04 A

GSI (%)

LSI (%)

N

Regressed

Body Weight
(g)
10.12 ± 0.55 A

December
2015
April 2016

1.72 ± 0.17 A

6.53 ± 0.24 A

20

Vitellogenic

13.39 ± 0.47 AB

0.44 ± 0.07 B

0.55 ± 0.05 A

3.30 ± 0.51 B

4.12 ± 0.39 B

10

April 2016

Early Mature

15.58 ± 0.85 BC

1.07 ± 0.10 C

0.66 ± 0.07 A

6.78 ± 0.34 C

4.21 ± 0.43 B

14

April 2016

Fully Mature

14.54 ± 0.77 BC

1.23 ± 0.08 C

0.56 ± 0.05 A 8.58 ± 0.57 CD

3.87 ± 0.32 B

14

May 2016

Ovulating

17.40 ± 1.02 C

2.09 ± 0.45 D

0.80 ± 0.11 A

4.54 ± 0.36 B

4

12.36 ± 3.2 D
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Figure 2.3 Mean (±SEM) plasma testosterone (A), 17β-estradiol (B), and maturation
inducing steroid (C) levels (pg/mL) characterized over the developmental cycle in female
mummichog with ovaries containing a majority of cortical alveoli (regressed: R),
vitellogenic (V), early mature (EM), late mature (fully mature: FM) or ovulated (OV)
follicles. Different letters indicate significant differences. The number of females
sampled at each point were 15, 12, 16, 14, and 4, respectively, for each hormone.
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Figure 2.4. Mean (±SEM) follicular in vitro production of basal testosterone (A), hCGstimulated testosterone (B), basal 17β-estradiol (E2; C), hCG-stimulated E2 (D), basal
maturation inducing steroid (MIS; E), and hCG-stimulated MIS (F) levels (pg/mL),
characterized over the ovarian development cycle in cortical alveoli (stage 1),
vitellogenic (stage 2), early mature (stage 3), late mature (stage 4) and ovulated (stage 5)
follicles. Different letters indicate significant differences. N = 10, 14-15, 11-13, 13-15,
and 8-9 for stages 1-5, respectively.
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Figure 2.5. Fold increase of hCG-stimulated to basal hormone production of testosterone
(A), 17β-estradiol (B) and maturation inducing steroid (C) characterized over the ovarian
development cycle in cortical alveolus (stage 1), vitellogenic (stage 2), early mature
(stage 3), late mature (stage 4) and ovulated (stage 5) follicles. Different letters indicate
significant differences. N = 10, 14-15, 11-12, 13-15, and 8-9 for stages 1-5, respectively.
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Figure 2.6. Expression of ESR1 (A), ESR2b (B), FSHr (C), and LHr (D) in mummichog
whole ovaries dominated by cortical alveoli (regressed: R), vitellogenic (V), early mature
(EM), late mature (fully mature: FM) or ovulated (OV) follicles. Data were normalized to
ESR2a and displayed as the fold change relative to the R stage. Values represent the
mean ± S.E.M. N= 8-9, 10, 14, 14, and 4, for stages 1-5, respectively, as determined by
qPCR. Different letters indicate significant differences.
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Figure 2.7. Expression of StAR (A), CYP11 (B), CYP17 (C), and CYP19a1 (D) in
mummichog whole ovaries dominated by cortical alveoli (regressed: R), vitellogenic (V),
early mature (EM), late mature (fully mature: FM) or ovulated (OV) follicles. Data were
normalized to ESR2a and displayed as the fold change relative to the R stage. Values
represent the mean ± S.E.M. N= 9, 10, 14, 14, and 4, for stages 1-5, respectively, as
determined by qPCR. Different letters indicate significant differences.
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Figure 2.8. Liver expression of ESR1 (A), ESR2a (B), ESR2b (C), and VTG1 (D) in
mummichog with ovaries dominated by cortical alveoli (regressed: R), vitellogenic (V),
early mature (EM), late mature (fully mature: FM) or ovulated (OV) follicles. Data were
normalized to 18sRNA and displayed as the fold change relative to the R stage. Values
represent the mean ± S.E.M. N= 12, 10, 13-14, 12-14, and 4, for stages 1-5, respectively,
as determined by qPCR. Different letters indicate significant differences.
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Figure 2.9. Stage specific expression of ESR1 (A), ESR2b (B), FSHr (C), and LHr (D) in
mummichog with cortical alveoli tissue (stage 1), vitellogenic (stage 2), early mature
(stage 3), and late mature (stage 4) follicles. Data were normalized to adjusted values of
ESR2a and displayed as the fold change relative to stage 1. Values represent the mean ±
S.E.M. N= 8-9, 8, 9, and 7-8, for stages 1-4, respectively; N= 7 for stage 5 (ESR2b only)
as determined by qPCR. Different letters indicate significant differences.
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Figure 2.10 Stage specific expression of StAR (A), CYP11 (B), CYP17 (C), CYP19a1
(D) in mummichog with cortical alveoli tissue (stage 1), vitellogenic (stage 2), early
mature (stage 3), and late mature (stage 4) follicles. Data were normalized to adjusted
values of ESR2a and displayed as the fold change relative to stage 1. Values represent the
mean ± S.E.M. N= 8-9, 8, 8-9, and 7-8, for stages 1-4, respectively, as determined by
qPCR. Different letters indicate significant differences.
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Table 2.4 Unstimulated (basal) and human chorionic gonadotropin (hCG)-stimulated testosterone (T) and maturation inducing steroid
(MIS) levels from ovarian follicles at different stages of maturation [stage 2 (vitellogenic), stage 3 (early mature), stage 4 (late
mature)], exposed to solvent control (ethanol; s ctrl) and increasing concentrations of 17α-ethinyl estradiol (EE2). The hormone levels
are presented as mean ± S.E.M. values (pg/mL). Mean fold increase is shown to compare hCG-stimulated production to basal
production, per treatment and stage. There are no significant differences in T or MIS production among treatments (solvent control, 50
nM EE2, 100 nM EE2, 250 nM EE2) per stage, within groups (basal or hCG-stimulated). There are no significant differences in fold
increase among treatments, per stage. hCG-stimulated hormone production is significantly higher than basal hormone production, per
stage, for each hormone. Average basal hormone production significantly increases with stage, for each hormone. N = 7-8 for each
treatment per stage. P-values from statistical tests performed on T and MIS data are found in Supplementary Table S2.2.
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Hormone

T

EE2
Stage 2
Treatment Basal hCG+
Fold Increase
S Ctrl

8.3 ±
1.2
9.6 ±
1.1
11.8
± 0.9
13.5
± 1.0
1.8 ±
0.4

30.3 ±
4.9
24.3 ±
3.8
21.5 ±
3.1
32.3 ±
6.7
30.8 ±
17.2

50 nM

1.9 ±
0.5

43.1 ±
16.9

46.3 ± 13.4

13.0
± 3.3

100 nM

1.7 ±
0.4

24.3 ±
8.0

23.1 ± 12.1

12.7
± 3.1

250 nM

2.1 ±
0.3

56.7 ±
18.4

32.3 ± 9.38

12.9
± 2.7

50 nM
100 nM
250 nM
MIS

S Ctrl

4.0 ± 0.6

Basal hCG+

2.0 ± 0.5
1.9 ± 0.3
2.4 ± 0.6
48.8 ± 20.0

26.2
± 4.1
25.5
± 4.2
28.7
± 4.3
32.8
± 4.1
12.2
± 2.1

235.5
± 52.0
143.8
± 15.7
217.4
± 35.1
249.4
± 37.9
1456.2
±
508.8
1220.3
±
199.6
1486.1
±
436.2
1518.4
±
286.9

Stage 3
Fold Increase

Basal

Stage 4
hCG+

66.2 ±
16.5
74.6 ±
13.2
64.4 ±
11.4
61.2 ±
12.5
35.0 ±
8.4

237.2 ±
59.9
193.3 ±
68.4
267.0 ±
58.9
247.6 ±
47.9
247.4 ±
45.7

187.0 ± 64.5

36.4 ±
9.4

396.3 ±
126.6

14.3 ±
4.0

188.6 ± 53.4

35.7 ±
8.9

301.1 ±
68.3

19.0 ±
6.9

135.1 ± 31.7

34.1 ±
8.8

485.5 ±
176.0

28.3 ±
10.9

14.1 ± 4.1
9.7 ± 3.9
9.5 ± 2.7
7.6 ± 1.4
216.5 ± 90.7

Fold
Increase
5.63 ±
2.4
5.05 ±
2.2
4.9 ± 1.5
5.8 ± 1.5
14.9 ±
5.8
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Table 2.5 Unstimulated (basal) and human chorionic gonadotropin (hCG)-stimulated P450 aromatase (CYP19a1) and luteinizing
hormone receptor (LHr) gene expression of ovarian follicles at different stages [stage 1 (cortical alveolus), stage 2 (vitellogenic), stage
3 (early mature), stage 4 (late mature)] of maturation exposed to solvent control (ethanol; s ctrl) and increasing concentrations of 17αethinyl estradiol (EE2). Gene expression is presented as fold increase to the 0-hour control, per stage, normalized to β-actin (mean ±
S.E.M). values (pg/mL). One-way ANOVA was completed to assess gene expression of CYP19a1 or LHr among treatments (basal or
hCG-stimulated 0-hour control, solvent control, 50 nM EE2, 100 nM EE2, 250 nM EE2) per stage. Different letters, or astericks,
indicate significant differences among treatments, within stages of an individual gene. There were no significant differences among
treatments, within stages of LHr expression. N = 7-8 for each treatment per stage. (p>0.05, ANOVA followed by Tukey post-hoc test).
P-values from statistical tests performed on CYP19a1 and LHr data are found in Supplementary Table S2.3.
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Gene

EE2
Stage 1
Treatment
Basal
hCG+
Oh
1 ± 0.24 *
CYP19a1
S Ctrl
0.23 ±
0.23 ±
0.04
0.06
50 nM
0.18 ±
0.20 ±
0.02
0.04
100 nM
0.21 ±
0.18 ±
0.05
0.02
250 nM
0.18 ±
0.25 ±
0.01
0.04
Oh
1 ± 0.14
LHr
S Ctrl
1.00 ±
1.19 ±
0.14
0.14
50 nM
1.62 ±
1.10 ±
0.12
0.21
100 nM
1.30 ±
1.37 ±
0.17
0.09
250 nM
1.07 ±
1.47 ±
0.13
0.35

Stage 2
Basal
hCG+
B
1 ± 0.15
0.06 ±
1.22 ±
0.01 A
0.40 B
0.07 ±
1.82 ±
0.02 A
0.40 B
0.08 ±
1.14 ±
0.02 A
0.27 B
0.10 ±
1.94 ±
0.03 A
0.53 B
1 ± 0.27
1.18 ±
0.91 ±
0.30
0.20
1.44 ±
0.92 ±
0.51
0.18
1.18 ±
0.69 ±
0.24
0.17
1.18 ±
0.74 ±
0.35
0.14

Stage 3
Basal
hCG+
C
1 ± 0.21
0.07 ±
6.11 ±
0.01 A
1.65 B
0.09 ±
7.37 ±
0.02 A
1.82 B
0.09 ±
6.22 ±
0.02 A
1.26 B
0.09 ±
5.10 ±
0.01 A
0.90 B
1 ± 0.13
0.65 ±
0.62 ±
0.09
0.09
0.86 ±
0.67 ±
0.12
0.11
0.79 ±
0.62 ±
0.11
0.05
0.76 ±
0.71 ±
0.14
0.08

Stage 4
Basal
hCG+
A
1 ± 0.32
0.19 ±
5.67 ±
0.04 A
2.12 B
0.27 ±
5.90 ±
0.10 A
1.71 B
0.28 ±
7.01 ±
0.07 A
2.38 B
0.30 ±
7.06 ±
0.06 A
1.88 B
1 ± 0.13
0.54 ±
0.71 ±
0.13
0.12
0.65 ±
0.59 ±
0.25
0.05
0.63 ±
0.76 ±
0.11
0.16
0.64 ±
0.79 ±
0.12
0.12
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2.5 Discussion
This study further develops the estuarine mummichog as a model species for
understanding the reproductive physiology of teleosts. The study confirmed that, similar
to other work in mummichog (Lin et al., 1987), E2 is produced by the ovarian follicles
from the cortical alveolus stage to late maturation, distinguishing this species from many
other teleosts, in which E2 levels rise from cortical alveolus to completion of
vitellogenesis and drop prior to maturation (Clelland and Peng, 2009). It is the first study
to demonstrate changes in gonadal steroidogenic enzymes and ERs, hepatic VTG1 and
ERs, and brain aromatase gene expression across the stages of female mummichog
maturation. The expression of ERs, VTG1 and CYP19a1 are associated with patterns of
plasma and in vitro E2 levels throughout ovarian development, while CYP17 expression
is not associated with the patterns of E2. While other studies have suggested that ovarian
LHr and aromatase gene expression are estrogen-responsive in fish (Liu et al., 2013;
Lyssimachou et al., 2006), addition of EE2 to in vitro ovarian follicle incubations had no
effect. Overall, these studies support the hypothesis that the tolerance exhibited by
mummichog to exogenous estrogens could be partly attributable to continuously high
levels of E2 present in the maturing ovary.
Plasma T and E2 were measured in female mummichog throughout
recrudescence, in reproductively regressed to ovulating fish; plasma hormone patterns of
T and E2 were generally similar to those previously demonstrated in mummichog (Lin et
al., 1987; Shimizu 2003). Plasma T levels were highest in fully mature fish, with no
significant differences between regressed and early mature stages. This is similar to
Shimizu (2002), in which plasma levels of T dramatically increased in pre-spawning
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periods; T levels dropped dramatically during the late spawning-post spawning period
(Shimizu 2002). Given T’s role as the precursor to E2 in the maturing ovary (Nagahama
and Yamashita, 2008; Sabet et al., 2009), it is not surprising in the present study that
higher levels of plasma T generally associated with higher levels of plasma E2. Plasma E2
levels increased dramatically from regressed to fully mature stages with significant
differences between the progressive stages of maturation. These findings are similar to
Shimizu (2002), in which a substantial increase in plasma E2 was demonstrated during
pre-spawning periods, and eventually dropped significantly during the late-spawning to
post-spawning period. T and E2 production trends in this study differ from other fish
species, as plasma T and E2 levels peak during the pre-spawning period in rainbow trout
(Oncorhynchus mykiss; Whitehead et al., 1978), goldfish (Carassius auratus; Schreck &
Hopwood, 1974), and caspian kutum (Rutilus kutum; Sabet et al., 2009). Plasma T rose in
association with E2 and reaching reproductive maturity in common carp (Cyprinus
carpio; Taghizadeh et al., 2013), and ribbed gunnel (Dictyosoma burger; Hwang et al.,
2012). Plasma T and E2 levels rose in association with vitellogenesis in catfish
(Heteropneustes fossilis; Lamba et al., 1983), rainbow trout (Zohar and Billard, 1984),
and Persian sturgeon (Acipenser persicus; Hosseinzade et al., 2012). Plasma E2 levels
from previous studies ranged from 1500 pg/mL in spring to 11000 pg/mL in the summer,
750 pg/mL in autumn, and back to 1500 pg/mL in late autumn/early winter (Shimizu et
al., 2003). Plasma E2 levels from the current study are dependent on stage of ovarian
development and appear to be expressed at a lower range when compared to Shimizu et
al. (2003) work; however, this could be caused due to the differences in sub-species of
mummichog utilized in the studies, as well as differences in methodology. Although
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difficult to compare between species and studies, plasma E2 levels in mummichog within
the current study were lower than plasma E2 levels measured in rainbow trout and Persian
sturgeon during peak production; however, plasma E2 in mummichog were much higher
than plasma E2 levels in common carp (Hosseinzade et al., 2012; Taghizadeh et al., 2013;
Whitehead et al., 1978). Reproductive processes in teleost fish are controlled and
regulated by a balance and interconnectivity among various hormones; these hormones
also regulate other processes such as growth and development and osmoregulation
(Menuet et al., 2005; McCormick, 2011; Ramezani-Fard et al., 2013). The association of
changes in gonadal steroid plasma levels with gonad condition has been proven to be
valuable in understanding the endocrine control of reproduction in teleosts, as hormone
levels detected in plasma can be produced from tissues other than the gonads, such as the
interrenal glands (Cornish, 1998). T and E2 plasma results from the current study suggest
plasma T and E2 are dependent on the stage of ovarian development, verifies previous
mummichog work, and confirms T and E2 are regulated differently in mummichog as
compared to other teleosts.
T and E2 production were measured from basal (control) and stimulated (with
hCG: analogue to LH) ovarian in vitro incubations from reproductively maturing fish
(regressed to ovulating). The in vitro steroid production in regressed ovaries is most
likely artificially high because of a higher tissue weight per well for regressed ovarian
tissue compared to vitellogenic follicles. Fold changes of hCG-stimulated to basal steroid
production, between regressed and vitellogenic ovaries, did not differ; therefore, the
decline in hormone production seen in vitellogenic follicular in vitro incubations is most
likely due to the difference in tissue weight per well, and therefore, the interpretation of
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results is focussed on vitellogenic to ovulated stages. Focussing on vitellogenic to
ovulated stages, higher levels of unstimulated in vitro T generally associated with high
levels of unstimulated in vitro E2. Unstimulated in vitro T levels were highest during late
maturation, and had no significant differences in expression among the vitellogenic, early
maturation and ovulated stages, whereas E2 levels significantly increased throughout the
cycle and peaked during early to late maturation. These results are similar to previous
mummichog work, in which Lin et al. (1987) determined that T production from basal
follicles peaked during maturational stages, and that E2 production from basal follicles
consistently increased throughout the cycle and peaked during maturational stages. This
differs from other teleosts, as a shift is usually present when E2 levels rise throughout the
earlier stages of the ovarian development cycle, and drop prior to early maturation to
allow for significantly increased levels of MIS, which are required to complete
maturation of the oocyte (Nagahama and Yamashita, 2008). This shift was not
demonstrated in the current study, nor in previous mummichog work (Lin et al., 1987). In
zebrafish, unstimulated in vitro T and E2 levels increase during growth stages of the cycle
and drop prior to early maturation (Clelland and Peng, 2009). In vitro T and E2
progressively rise through the ovarian development cycle and drop during the late stages
of vitellogenesis in rainbow trout (Breton et al., 1975), amago salmon (Oncorhynchus
rhodurus; Kagawa et al., 1983), and goldfish (Kagawa et al., 1984). In vitro E2
production from ovarian follicles across development in mummichog from the current
study are similar to previous mummichog studies as Lin et al. (1987) demonstrated a
range of ~900-1500 pg/mL of E2, varying by stage of ovarian development. However, E2
levels from the current study is much higher than E2 production in amago salmon ovarian
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follicles (Kagawa et al., 1983). In the current study, unstimulated in vitro T and E2 trends
associated with their respective plasma trends; this suggests that the majority of T and E2
produced is from the gonads, similar to most female vertebrates (Thomas, 2008). This
study confirms previous mummichog studies and suggests that T and E2 production
correlate with vitellogenesis, as well as with final maturation in mummichog without an
E2 drop prior to maturation; as noted in the following, this warrants further investigation
into the regulation of the steroiodgenic pathway during maturation in mummichog.
This is the first study to measure plasma MIS levels in recrudescing mummichog.
MIS levels increased significantly from early maturation to ovulating stages, and were
dissimilar to T and E2 as MIS did not drop off after maturation. These findings from the
current study are similar to other species such as rainbow trout, in which serum MIS
levels were highest in female rainbow trout, rockfish (Sebastes taczanowskii) and amago
salmon undergoing final oocyte maturation and ovulation (Campbell et al., 1980;
Nagahama et al., 1991; Young et al. 1983), or in ribbed gunnel during spawning and
post-spawning (Hwang et al., 2012). In the current study, unstimulated in vitro MIS
trends followed similar trends as MIS plasma, with the exception that in vitro MIS
increased significantly between vitellogenic and late maturation ovarian follicles, and
plasma significantly increased between late maturation and ovulation. This suggests a
time lag between gonadal production and manifestation in the plasma of MIS, perhaps
due to the low levels of MIS produced relative to T and E2. These findings are similar to
Lin et al. (1987) which demonstrated that MIS production from stimulated follicles (basal
MIS levels were non-detectable) peaked during late vitellogenesis – early maturation
stages. These findings from the current study are also similar to in vitro MIS production
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trends in other teleosts, even though no dramatic shift in the steroidogenic pathway from
E2 to MIS was detected prior to oocyte maturation. Follicular MIS levels peak during
early maturation in zebrafish (Clelland and Peng, 2009), and in maturing and ovulated
follicles in amago salmon (Young et al., 1983). MIS was confirmed to be the primary
inducer of GVBD (germinal vesicle breakdown) in amago salmon, rainbow trout and
goldfish post-vitellogenic oocytes (Nagahama, 1983). This study suggests the rise in MIS
is the primary event which triggers final oocyte maturation, as opposed to the proceeding
decline in E2 levels usually found in other teleosts. The action of MIS on final oocyte
maturation is not direct as it is mediated by a complex interaction of several factors, such
as cytoplasmic factor and MPF (maturation promoting factor) (Nagahama and
Yamashita, 2008; Senthilkumaran et al., 2004); therefore, the cause of increasing plasma
and in vitro MIS levels in ovulating mummichog can be influenced by multiple other
factors. This study has only considered the presence of T, E2 and MIS across maturation
in mummichog. Other steroid hormones and gonadotropins, such as progesterone, FSH
and LH, are involved in ovarian development and can possibly influence the production
of plasma and in vitro T, E2 and MIS, directly or indirectly (Hosseinzade et al., 2012),
which warrants further studies.
hCG-stimulated in vitro T, E2 and MIS hormone production was significantly
higher than unstimulated in vitro hormone production. hCG is able to stimulate oocyte
maturation and ovulation in many teleosts, in the same fashion as LH (Harvey and Hoar,
1979; Zuberi et al., 2011). Oocyte maturation in teleosts is typically first initiated by an
LH surge in maturing oocytes, which triggers the production of 17α-hydroxyprogesterone
from the thecal cells, which is then converted into MIS (Nagahama and Yamashita, 2008;
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Patino and Sullivan, 2002). The current study demonstrated that the steroidogenic
response of ovarian follicles to hCG is highly dependent on the stage of maturation; early
mature, followed by late mature ovarian follicles, were most responsive to hCG, as they
exhibited the highest increase in hormone production from unstimulated in vitro
production. This differs from previous studies, as Lin et al. (1987) showed a maximal
increase in hormones T, E2 and MIS in late vitellogenic follicles with FPE (Fundulus
pituitary extract; acts similar to LH in terms of maturation induction) stimulation;
however, the differences in stage response could be due to differences between FPE and
hCG. In other teleosts, such as catfish, hCG production causes maximal production of T
in maturing follicles, and a maximal production of E2 in vitellogenic follicles (Kagawa et
al., 1984). Similarly, in amago salmon, SG-G100 (purified chinook salmon
gonadotropin) could stimulate E2 in vitellogenic follicles, whereas T could be stimulated
in maturing follicles (Kagawa et al., 1983). Since hCG displays LH bioactivity as it binds
to gonadal LH receptors and stimulates ovarian development and maturation (Mananos et
al., 2009), the present study suggests that maturing follicles (primarily early mature) in
mummichog are most LH-responsive and presumably will have the highest expression of
LH receptors, which can be confirmed with the gene expression data of LH receptors
from this study. E2 has been shown to reduce the action of hCG in gonadal incubations of
goldfish ovaries (Post, 1994). It is worthwhile to further examine how mummichog
ovaries can consistently respond to hCG with continuously high levels of E2 produced
until late maturation.
The current study is the first to examine gene expression changes in the
steroidogenic enzymes and receptors within the ovary (whole tissue and isolated
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follicles), liver and brain, across the ovarian development cycle in mummichog (from
reproductively regressed to ovulating). This study showed differences in expression
trends between whole ovary tissue and isolated follicles (separated per group), which
demonstrated different regulation patterns of these steroidogenic enzymes and receptors
between isolated follicles and whole ovary tissue. The expression results from isolated
follicles provide an accurate representation of steroidogenic receptor and enzyme activity
from specific follicular stages (cortical alveolus, vitellogenic, early mature, late mature,
and ovulated); because mummichog are group-synchronous spawners, ovarian sections
from regressed, vitellogenic, early mature, fully mature and ovulating fish containing
follicular mixes (>75% stage-dominant, ~25% other) provide a less precise representation
of follicular-specific activity. Therefore, the focus of the discussion will be on the
isolated follicles (by 100% stage). Stage 5 (ovulated follicles) were excluded from
analysis because expression levels were non-detectable.
Gene expression of enzymes in the steroidogenic pathway (StAR, CYP11,
CYP17, and CYP19a1) were measured and characterized across stages in the maturing
ovary. The steroidogenic pathway is involved in the enzymatic synthesis of sex steroids
from cholesterol. StAR (aids in the transport of cholesterol across the mitochondrial
membrane) continues to increase in expression throughout the ovarian development cycle
and peaks during the later stages. These trends in StAR expression parallel the increasing
pattern of E2 throughout the stages of maturation. StAR expression in the current study is
similar to StAR expression in rainbow trout (Sreenivasulu and Senthilkumaran, 2009),
but differs from zebrafish StAR expression as there are no significant changes in
expression across all stages in zebrafish (Ings and Kraak, 2006). StAR seems to be
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associated with ovarian development and E2 production. It is possible that increases in
StAR expression can also be triggered by LH-mediated signaling pathways. As the
transport of cholesterol is a rate-determining step for steroidogenesis and StAR is the
putative key rate-limiting mediator in acute regulation of steroidogenesis (Nagahama and
Yamashita, 2008; Young et al., 2005), it emphasizes the importance of StAR throughout
oocyte maturation and its possible role in maintaining high levels of steroidogenic
precursors, such as cholesterol, pregnenolone, and progesterone.
CYP11 (converts cholesterol to pregnenolone) expression increases throughout
the ovarian development cycle, peaks in expression during early maturation, and drops in
expression during late maturation. These trends in CYP11 expression parallel the
increasing pattern of E2 throughout the stages of ovarian development discussed
previously. CYP11 expression is also similar to other teleosts (Kumar et al., 2000) as
CYP11 in catfish increased from ovarian recrudescence to vitellogenesis (elevations in
CYP11 expression corresponded to E2 production patterns); however, the current study
differs from zebrafish expression as CYP11 expression decreased throughout the cycle in
zebrafish (Ings and Van Der Kraak, 2006). CYP11 is a critical enzyme involved in the
synthesis of major sex hormones, as it catalyzes the enzymatic reaction following the
rate-limiting step in steroidogenesis (Kumar et al., 2000). In the current study, CYP11
follows E2 production patterns as it is associated with oocyte maturation, suggesting
CYP11 expression may mediate production of final steroidogenic hormones.
CYP17 (P450 C17: converts pregnenolone to 17α-hydroxypegnenolone and then
to dehydroepiandrosterone, or converts progesterone to 17α-hydroxyprogesterone and
then androstenedione) peaks in cortical alveolus staged follicles and remains equally and
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lowly expressed from vitellogenesis to late maturation. CYP17 trends in mummichog are
similar to those in zebrafish, where CYP17 expression decreases throughout the ovarian
development cycle (Ings and Van Der Kraak, 2006); however, CYP17 expression trends
in the current study differ from catfish expression trends as CYP17 expression in catfish
spiked within spawning ovaries and dropped during regressed and pre-spawning stages
(Sreenivasulu and Senthilkumaran, 2009). In the current study, CYP17 in mummichog
does not appear to parallel E2 levels. CYP17 was described as a critical enzyme involved
in the initiation of maturational events in fish (Senthilkumaran et al., 2004). Thus, the
lack of increase in the expression of CYP17 throughout recrudescence in mummichog,
may be explained by the lack of an E2 to MIS switch at maturation, as the expression
patterns of CYP17 were previously suggested to have a role in the switch (Clelland and
Peng, 2009).
CYP19a1 (P450 aromatase: converts T to E2) had no significant differences in
expression between the cortical alveolus stage and early maturation stage, and
demonstrated a decline in expression during late maturation. CYP19a1 expression in the
current study differs from other teleosts. CYP19a1 is suspected to be an estrogenresponsive gene; CYP19a1 expression correlates with the onset of ovarian recrudescence
and vitellogenesis in catfish, closely mirroring E2 production trends (Kumar et al., 2000).
CYP19a1 expression in zebrafish decreases as the ovarian development cycle progresses
(Ings and Van Der Kraak, 2006), and dramatically declines in expression after
vitellogenesis in catfish (Kumar et al., 2000) and rainbow trout (Gohin et al., 2010). In
catfish, CYP19a1 had the most dramatic increase in expression during recrudescence and
vitellogenesis, when compared to the other P450 enzymes (Kumar et al., 2000),

88

suggesting CYP19a1 is potentially the most crucial enzyme involved in regulating
hormones (such as E2) for ovarian recrudescence and vitellogensis. This holds true in the
current study on mummichog as the expression pattern parallels the increasing pattern of
E2 throughout the stages of ovarian development until early maturation; however, the
drop off in CYP19a1 expression at late maturation does not follow E2 patterns and
warrants further studies to determine what may be causing the drop-off in CYP19a1.
P450 aromatase is also expressed in the brain (CYP19b), which showed no
significant differences in expression across ovarian development. Because P450
aromatase is a key enzyme associated with E2 regulation and ovarian development, it was
important to assess the expression in brain, in addition to the ovary. P450 aromatase was
similarly expressed between ovary and brain, with the exception that brain expression of
CYP19b was continuous throughout ovarian development, including ovulation. This
indicates regulation of local brain E2 production is independent of gonadal
steroidogenesis, as CYP19b is related to estrogen-dependent neurogenesis, which is
continuous through adulthood in fish (Forlano et al., 2001; Pellegrini et al., 2007).
This is the first study to measure gene expression of estrogen receptors (ESR1,
ESR2a, and ESR2b) across stages in maturing ovary of mummichog. E2 signaling
pathways involve binding to the different subunits of estrogen receptors in target organs
to stimulate biological activity (Hall et al., 2001; Nagler et al., 2012). The pattern of ER
expression should correlate with E2 biological function and regulation; however, ERs
could be down-regulated in some tissue as E2 increases to regulate E2 effects. For
example, ERs in goldfish ovary, liver and brain demonstrated differential patterns of all
ER-subtype expression during ovarian development, potentially altering ER-mediated
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processes across tissues (Marlatt et al., 2008). RT-PCR was applied to determine the
tissue distribution of ERs in mummichog and found that all ER subtypes were primarily
found in the gonad or liver of males and females, but sex differences in mRNA levels
were gene- and tissue-specific (Greytak and Callard, 2007).
Follicular expression of ESR1 paralleled E2 trends, as ESR1 expression had no
significant differences between the cortical alveoli and early mature stages, and then
significantly decreased in expression during late maturation. ESR1 is the only subtype
that has been linked to biological function, i.e. vitellogenin synthesis in liver and E2
regulation in ovary (Chakraborty et al., 2011). ESR1 trends are generally similar to
Greytak and Callard (2007)’s study which demonstrated an increase in ovary ESR1
expression in reproductively active female mummichog, compared to reproductively
inactive female mummichog. Mummichog ESR1 expression in the current study is also
similar to other teleosts, as Nagler et al. (2012) demonstrated low and relatively
unchanging ESR1 expression in the ovary of rainbow trout. ESR2a expression in the
current study remained stable across the stages in ovary, whereas ESR2b expression
peaked in the cortical alveolus stage and decreased throughout the cycle. ESR2a
expression patterns generally follow Greytak and Callard (2007)’s study as they
demonstrated no changes in expression between reproductively active or inactive gonadal
ESR2a expression; however, ESR2a expression patterns from the current study do not
follow patterns in other teleosts such as rainbow trout. Mummichog ESR2b expression
patterns from the current study do not follow Greytak and Callard (2007)’s study as they
demonstrated no changes in expression between reproductively active or inactive gonadal
ESR2b expression; however, mummichog ESR2b expression patterns from the current
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study are similar to other teleosts (Nagler et al., 2012). Nagler et al. (2012) also showed
that ESR2a was expressed much higher than ESR2b, with both ERβ subtypes having
expression which peaked during earlier stages in follicular development and gradually
decreased until spawning began. In the current study, the various estrogen receptor
subtypes other than ESR1, are expressed differently throughout the cycle, in differing
tissues, and are not always associated with the pattern of E2. The function of ERβ
subtypes has not been determined, but ERβ subtypes can be further examined in various
tissues to determine whether their expression across the ovarian development cycle
correlates to endocrine mediators, such as gonadotropins, steroids, or intracellular
regulators.
ESR1 and VTG1 expression in the liver were associated with E2 regulation, in
which ESR1 expression was highest during ovulation, and VTG1 expression peaked
during ovulation. Vitellogenin (a female-specific lipoprotein) is synthesized in the liver
under the stimulation of ovarian E2 and is secreted into the blood and transported to the
ovary where it is taken up into the oocytes to stimulate egg yolk protein production
during development of the oocyte (Hoar et al., 1983). It is expected that ESR1 expression
in the liver will be associated with VTG1 expression, as ESR1 is linked to E2 function.
Hepatic ESR1 expression in mummichog in the current study differed from other teleosts,
as ESR1 expression in rainbow trout remained fairly static until the end of the spawning
period, and then significantly increased in post-spawning fish (Nagler et al., 2012).
VTG1 expression, on the other hand, corresponds to other teleosts as VTG1 expression in
zebrafish liver is tightly coupled to an increase in E2 activity within maturing females
(Levi et al., 2009). In the current study, hepatic ESR2a peaked during the cortical
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alveolus stage and decreased throughout the cycle, whereas ESR2b peaked during
vitellogenesis and had low expression across all other stages. Neither ESR2a nor ESR2b
patterns follow expression patterns in other teleosts. In rainbow trout, ESR2a had a
significant peak in expression in regressed stages, and ESR2b showed a sharp decrease in
regressed stages (Nagler et al., 2012). These results from the current study suggest that
ESR1 expression is closely related to E2 levels and vitellogenin expression within
mummichog; the relationships for estrogen receptors ERβ1 and ERβ2 with ovarian
development are still unclear.
Gonadotropin receptors (FSHr and LHr) expression was measured and
characterized across stages in the maturing ovary. Gonadotropins are regulated through
the expression of their corresponding receptors; expression of the gonadotropin receptor
genes vary with reproductive state, partly due to feedback of FSH, LH and steroids
including E2, T and MIS (Moles et al., 2007). In the current study, follicular expression
of FSHr peaked during vitellogenesis and had low expression in all other stages. These
follicular FSHr results corresponded to previous mummichog work (Ohkubo et al.,
2013), which demonstrated a peak in follicular FSHr expression during vitellogenesis as
well. The follicular FSHr results from the current study also corresponded with other
teleosts, as FSHr expression is expected to peak near vitellogenesis and drop prior to
maturation (Clelland and Peng, 2009). In zebrafish, FSHr increased from the primary
growth stage to vitellogenesis, where it peaked (Kwok et al., 2005). FSH is primarily
involved in regulating gonadal steroidogenesis in the early ovarian developmental stages,
especially during vitellogenesis (Ohkubo et al., 2013; Swanson et al., 1991). FSH’s
dominant role in vitellogenesis is to stimulate E2 production and release from ovarian
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follicles (Nagahama and Yamashita, 2008); it also influences the increase in P450
aromatase expression in vitellogenic follicles, as noted in brown trout (Montserrat et al.,
2004). These expression trends from the current study suggest that FSHr correlates to
FSH is presumed actions on steroidogenesis during follicular growth and vitellogenesis;
however, FSHr is not associated with the increasing E2 levels in maturing mummichog
follicles. It may be that once stimulated, E2 levels are maintained by other factors
including intracellular receptors, cAMP (cyclic adenosine monophosphate) / pKA
(protein kinase A) pathway factors and calcium channels involved in intracellular signal
transduction pathways (Matagne et al., 2005; Menuet et al., 2005).
Follicular LHr expression patterns exhibited low expression during the cortical
alveolus stage, a peak in expression during vitellogenesis to early mature stages, and no
significant differences in expression between vitellogenesis to late maturation stages. The
follicular LHr results from the current study did not correspond to previous mummichog
work, as Ohkubo et al. (2013) demonstrated a peak in follicular LHr expression during
early maturation and low expression during vitellogenesis, and late maturation. A reason
for the discrepancy could be due to methodological differences as cortical alveolus staged
follicles were included in a separate analysis in Ohkubo et al. (2013)’s study.
Alternatively, the follicular LHr expression trends from the current study did correspond
to other teleosts. In zebrafish, LHr expression was low during the early stages of the
ovarian developmental cycle, but was significantly higher during vitellogenesis, and
peaked prior to oocyte maturation (Kwok et al., 2005). LH primarily regulates the final
stages of ovarian development and spawning (Breton et al., 1998; Tyler et al., 1997),
partially due to its ability to stimulate MIS production from ovarian follicles (Clelland
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and Peng, 2009; Nagahama and Yamashita, 2008). The surge in LH prior to maturation is
what is believed to cause the steroidogenic shift in E2 to MIS commonly found in teleosts
(Nagahama and Yamashita, 2008), as LH is said to inhibit the production of E2 prior to
maturation (Planas et al., 2000); however, mummichog continue to produce increasing
amounts of E2 with a high expression of LHr in maturing follicles. In the current study,
LHr expression is associated with hCG stimulation activity of in vitro hormone
production, with the exception that LHr is highest in vitellogenic and early maturation
follicles, whereas hCG stimulation caused the largest increase in hormone production
within early maturation and late maturation follicles. This could indicate that the increase
in gonadotropin receptors is required before the increase in gonadotropin occurs. It would
be beneficial to analyze FSH and LH levels across maturation in mummichog in further
studies to determine whether gonadotropin levels correlate with the patterns of their
receptors. The present study suggests that similar to other species, LHr expression
correlates to MIS levels and LH stimulation of maturation and this relationship is
independent of an E2 decline.
Basal and hCG-treated ovarian follicles, grouped by stage of ovarian
development, were exposed to 50-250 nM of EE2 for 24 hours, in vitro. The experiment
sought to examine the effect of EE2 on the in vitro production of T and MIS, and on the
gene expression of CYP19a1 and LHr. The goal was to provide insight on whether
tolerance exhibited by mummichog in vivo to exogenous estrogens may be partly
attributable to a lack of response to EE2 at the level of the ovary. The rationale for the
experimental design (concentration range and exposure time) was from previous in vitro
exposures of fish ovarian and liver cells to EE2. Hepatic cells in rainbow trout
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demonstrated a 20-30% increase in expression change of VTG1 to 1-10 nM of EE2 in
vitro after 24 hours (Hultman et al., 2015); zebrafish hepatocytes demonstrated a 1- to
10-fold increase in ER and VTG1 expression with 100 nM of EE2 in vitro for 24 hours
(Eide et al., 2014); and zebrafish ovarian cells demonstrated approximately a 10-fold
increase in LHr expression with 5 µM EE2 in vitro for 24 hours (Liu et al., 2013).
Adult female mummichog responses are generally resistant to in vivo EE2
exposure compared to other fish species. For example, egg production is not decreased at
nominal concentrations of 100 ng/L, or 84.1 ± 6.0% of nominal, for 28 days (Bosker et
al., 2016), female plasma E2 levels were not affected after a 14-day exposure to 250 ng/L
of EE2 (Doyle et al., 2013), and male and female plasma T levels were not affected after
a 14-day exposure to 500 ng/L (nominal) of EE2, or 247.9 ± 12.3 (average) ng/L (Hogan
et al., 2010). There was no effect of EE2 in the current study on either T or MIS
production (E2 was not measured due to high cross-reactivity to EE2 in the EIA analysis),
or gene expression (CYP19a1 and LHr) at any follicular stage. The results validate the
hypothesis that mummichog are more tolerant to EE2 than other teleosts. Liu et al. (2013)
conducted a 24 h EE2 in vitro exposure at 5 µM on zebra fish ovarian cells, causing an
approximate 10-fold increase in LHr expression; the ED50 (median effective dose) for
EE2 was 17.9 pM at 1.5 hours, which was similar to the ED50 of E2 (exposed at 5 nM).
hCG stimulation increased both hormone production and CYP19a1 expression in
incubated follicles. That hCG stimulation did not increase LHr expression at any stage of
maturation (cortical alveolus – late mature) was unexpected, as MIS levels did increase
with hCG stimulation. In Liu et al.’s (2013) study, the use of hCG resulted in an increase
in LHr expression in zebrafish; there was a 5-fold increase in LHr expression with only
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hCG stimulation, and an 8-fold increase in LHr expression with a combination of hCG
and 5µM EE2. Expression patterns of other steroidogenic enzymes can be explored to
provide insight on this discrepancy, such as 20β-HSD, which should increase in
expression after the induction of LH or hCG during oocyte maturation (Senthilkumaran et
al., 2002).The hormone and gene expression results after EE2 in vitro exposure adds
weight to the idea that mummichog ovarian follicles are resistant to exogenous estrogen,
and the previous work in the current study suggests high levels of E2 in maturing follicles
may cause this lack of sensitivity. It would be beneficial to further explore the extent of
EE2, in vitro, on mummichog ovarian follicles, with a broader concentration range and a
number of incubation time periods. The explanation for the lack of increase in LHr
expression with hCG also needs to be further explored as it could be contributing to the
lack of response to EE2 in mummichog.
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2.6 Conclusions
The current study provides confirmation of a continuously increasing production
of E2 in maturing follicles, supplemented by new molecular analysis of the gene
expression of key steroidogenic enzymes and hormone/gonadotropin receptors across the
ovarian steroidogenic pathway in mummichog. These differences exhibited in
mummichog ovarian development, along with no effect of exposure to EE2 on maturing
follicles, support the hypothesis that high estrogen levels during oocyte maturation may
be responsible for reduced sensitivity in mummichog to environmental estrogens. I.e. the
exposure of mummichog in vivo to EE2 does not manifest in molecular or biochemical
changes in the ovary, which in other fish is associated with cessation in egg production or
altered physiological steroid levels, as the ovary is adapted to continuous levels of E2
during maturation.
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Appendix A: Supplementary Material
Adjusting Normalizing Gene Calculation
When no gene was found to be steadily expressed across stages, such as in experiment 1C
(EE2 in vitro exposure), the gene that was most steadily expressed was adjusted through a
calculation (Ings and Van Der Kraak, 2006) to have constant expression. The calculation
is as follows:
𝐼𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙 𝐼𝑛𝑝𝑢𝑡 𝑉𝑎𝑙𝑢𝑒

Adjusted Value = 𝑀𝑒𝑎𝑛 𝐺𝑟𝑜𝑢𝑝 𝐼𝑛𝑝𝑢𝑡 𝑉𝑎𝑙𝑢𝑒 ÷ 𝑀𝑒𝑎𝑛 𝑜𝑓𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝐺𝑟𝑜𝑢𝑝 𝐼𝑛𝑝𝑢𝑡 𝑉𝑎𝑙𝑢𝑒
Reference group refers to the treatment group chosen to which to adjust all other
treatment groups. For instance, stage 1 was chosen as the reference group.
Stage 1 Mean = 0.0318
Stage 2 Mean = 0.0038
Stage 2 individual value example (fish #10) = 0.0042
Final adjusted value example (fish #10) = 0.0355
Standard Curve Equation Values
Table S2.1 Slope and y-intercept from standard curves of all primers used in this study.
Enzyme/Receptor

Gene

Tissue

Slope

Y-Intercept

P450 Aromatase Brain
Elongation Factor 1α
Estrogen Receptor α
Estrogen Receptor β1
Estrogen Receptor β2
Vitellogenin
18s RNA
Estrogen Receptor α
Estrogen Receptor β1
Estrogen Receptor β2
Follicle Stimulating Hormone
Receptor
Luteinizing Hormone Receptor
Steroidogenic Acute Regulatory
Protein
P450 Side Chain Cleavage
P450 C17
P450 Aromatase
β-Actin

CYP19b
EF1α
ESR1
ESR2a
ESR2b
VTG1
18sRNA
ESR1
ESR2a
ESR2b
FSHr

Brain
Brain
Liver
Liver
Liver
Liver
Liver
Ovary
Ovary
Ovary
Ovary

-3.3379
-3.7111
-3.5421
-3.7906
-3.2274
-3.7368
-3.7313
-3.1784
-3.4627
-3.3403
-3.3691

25.396
18.86
24.344
27.974
26.309
14.545
9.4068
28.321
27.244
26.485
26.8

LHr
StAR

Ovary
Ovary

-3.5261
-3.1238

26.57
26.84

CYP11a1
CYP17a1
CYP19a1
Actin

Ovary
Ovary
Ovary
Ovary

-3.2424
-3.0117
-3.4627
-3.2588

24.798
27.577
24.672
16.477
98

Normalizing Genes
0.05

ESR2a Expression (Raw Input Values)

0.045
0.04
0.035
0.03

0.025
0.02
0.015
0.01
0.005
0
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O

Stage of Ovarian Development

Figure S2.1. Expression (raw input values) of ESR2a in mummichog whole ovaries
dominated by cortical alveoli (regressed: R), vitellogenic (V), early mature (EM), late
mature (fully mature: FM) or ovulated (O) follicles. Values represent the mean ± S.E.M.
(N = 9, 10, 14, 14, 4 for stages 1-5, respectively) as determined by qPCR. There were no
significant changes across expression. (p = 0.298, ANOVA followed by Tukey post-hoc
test).
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0.0018

18sRNA Expression (Raw Input Values)
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Figure S2.2. Expression (raw input values) of 18sRNA in liver tissue from mummichog
with ovaries dominated by cortical alveoli (regressed: R), vitellogenic (V), early mature
(EM), late mature (fully mature: FM) or ovulated (OV) follicles. Values represent the
mean ± S.E.M. N = 12, 10, 14, 14, 4 for stages 1-5, respectively, as determined by qPCR.
There were no significant changes across expression. (p = 0.547, ANOVA followed by
Tukey post-hoc test).
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EF1α Expression (Raw Input Values)
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Figure S2.3. Expression (raw input values) of EF1α in brains from mummichog with
ovaries dominated by cortical alveoli (regressed: R), vitellogenic (V), early mature (EM),
late mature (fully mature: FM) or ovulated (OV) follicles. Values represent the mean ±
S.E.M. N = 12, 11, 15, 14, 4 for stages 1-5, respectively, as determined by qPCR. There
were no significant changes across expression. (p = 0.726, ANOVA followed by Tukey
post-hoc test).
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Additional Methods FlowCharts and Diagrams

Figure S2.4. Simplified flowchart of experimental protocols undertaken for hormone
analysis (plasma and in vitro), histology, and gene expression of whole tissue (ovary,
liver, and brain), explained in sections 2.3.2 of the methods.
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Figure S2.5. Simplified flowchart of experimental protocols undertaken for hormone
analysis and gene expression of separated ovarian follicles after a 24-hour EE2 in vitro
exposure, explained in sections 2.3.4 of the methods.
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A

B

Figure S2.6. Example in vitro plate setups for hormone analysis of basal and hCG
(human chorionic gonadotropin)-treated follicles across ovarian development (A),
explained in methods section 2.3.2 ii, and for hormone and gene analysis of the EE2 in
vitro exposure of ovarian follicles across ovarian development (B), explained in methods
section 2.3.4 ii.
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Brain Gene Expression Analysis
1.4

CYP19b Expression (Fold Change)
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Figure S2.7. Expression of CYP19b in brains from mummichog with ovaries dominated
by cortical alveoli (regressed: R), vitellogenic (V), early mature (EM), late mature (fully
mature: FM) or ovulated (OV) follicles. Values represent the Mean ± S.E.M. N = 12, 11,
15, 14, 4 for stages 1-5, respectively, as determined by qPCR. Data were normalized to
EF1α and displayed as the fold change relative to the R stage. There were no significant
changes across expression. (p = 0.256, ANOVA followed by Tukey post-hoc test).
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Table S2.2. P-Values from statistical tests performed on T (testosterone) and MIS
(maturation inducing steroid) hormone data from 24-hour in vitro ovarian follicles at
different stages of development [stage 2 (vitellogenic), stage 3 (early mature), stage 4
(late mature)] incubations with EE2 treatments (control, solvent control, 50 nM EE2, 100
nM EE2, 250 nM EE2) between groups (basal or hCG-stimulated).
Hormone/
Stage

2-way ANOVA
(Stage & Basal
Treatments)

T
2
3
4
MIS
2
3
4

0.822

1-way
ANOVA
(Stages from
Basal only)
0.00

0.779

1-way ANOVA
(Basal EE2
Treatments)

1-way
ANOpVA
(hCG+ EE2
Treatments)

1-way ANOVA
(Fold Increase)

0.114
0.093
0.669

0.513
0.363
0.574

0.088
0.281
0.939

0.884
0.258
0.976

0.439
0.688
0.981

0.208
0.842
0.834

0.00

Table S2.3. P-Values from statistical tests performed on CYP19a1 (P450 aromatase) and
LHr (luteinizing hormone receptor) gene expression data from 24-hour in vitro ovarian
follicles at different stages of development [stage 1 (cortical alveolus), stage 2
(vitellogenic), stage 3 (early mature), stage 4 (late mature)] incubations with EE2
treatments (basal or hCG-stimulated: control, solvent control, 50 nM EE2, 100 nM EE2,
250 nM EE2).
Gene

Stage

1-way ANOVA among
Treatments within Stage

CYP19a1

1
2
3
4
1
2
3
4

0.00
0.03
0.00
0.00
0.21
0.71
0.09
0.43

LHr
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3.1 Summary
This thesis further develops the estuarine mummichog as a model species for
understanding the reproductive physiology of teleosts. It has been confirmed that, similar
to other work in mummichog (Lin et al., 1987), 17β-estradiol (E2) is produced by the
ovarian follicles from the regressed (cortical alveolus) stages to late maturational stages,
distinguishing this species from many other teleosts, in which E2 levels rise from cortical
alveolus to completion of vitellogenesis and drop prior to maturation (Clelland and Peng,
2009). In most teleost fish, there is a marked shift from estrogens (such as E2) to
progestogens (such as maturation inducing steroid; MIS) as follicles progress to early
maturation. However, in mummichog there is no shift detected, as levels of E2 are
consistently higher in all stages of follicular development. Mummichog have also been
noted to be more tolerant to exogenous estrogen exposure, such as 17α-ethinyl estradiol
(EE2), compared to commonly studied teleosts; most freshwater species will respond to
environmentally-relevant concentrations (Armstrong et al., 2016), whereas mummichog
respond to much higher concentrations (if at all) (Bosker et al., 2016). The differences in
ovarian physiology and EDC (endocrine disrupting compound) responses amongst
species led to the hypothesis that provides the foundation for this thesis, which is that
continuous high levels of E2 produced in the maturing mummichog ovary may be a
reason for the species’ increased tolerance to EE2 exposure.
Plasma (from blood), ovary, liver and brain tissue, and ovarian follicles, were
collected from maturing mummichog and grouped into five stages of maturation;
follicular steroid production and/or gene expression in hormone signaling and
steroidogenic pathways were assessed by stage. Plasma and follicular production of E2
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increased as the ovarian development cycle progressed, and dropped after maturation;
MIS, however, was equally expressed during development and early maturation stages,
and increased in late maturation and ovulation stages. T (testosterone) levels
corresponded with E2 trends, whereas MIS peaked during late maturational stages. This
study also demonstrated that the steroidogenic response of ovarian follicles to hCG
(human chorionic gonadotropin) is highly dependent on the stage of maturation; early
mature, followed by late mature ovarian follicles, were most responsive to hCG. Because
hCG mimics LH (luteinizing hormone) bioactivity, as it binds to gonadal LH receptors
(LHr) and stimulates ovarian development and maturation (Mananos et al., 2009), the
present study suggests that maturing follicles (primarily early mature) in mummichog are
the most LH-responsive. This study suggests that T and E2 production correlates with
vitellogenesis and final maturation in mummichog, whereas MIS correlates only with
final maturation, with no E2 drop prior to maturation.
The current study is the first to examine changes in gene expression of
steroidogenic enzymes and receptors within the ovary (whole tissue and isolated
follicles), liver and brain, across the ovarian development cycle (from reproductively
regressed to ovulating) in mummichog. StAR (steroidogenic acute regulatory protein;
aids in the transport of cholesterol across the mitochondrial membrane), CYP11 (P450
side-chain-cleavage; converts cholesterol to pregnenolone), and LHr (luteinizing
hormone receptor; surge in LH prior to maturation is believed to be the main mediator
causing the steroidogenic shift in E2 to MIS) (Nagahama and Yamashita, 2008) follow
similar expression patterns as found in other teleosts. StAR and CYP11 follow the
general pattern of increasing E2 throughout the stages of maturation, whereas LHr shows
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an increase in expression, primarily with maturation. LH is said to inhibit the production
of E2 prior to maturation (Planas et al., 2000); however, mummichog continue to produce
increasing amounts of E2 with a high expression of LHr in maturing follicles.
Differences between mummichog and other teleosts in maturational gene
expression include the expression of P450c17 (catalyzes the hydroxylation of
pregnenolone to yield 17α-hydroxypregnenolone and then dehydroepiandrostone, or the
hydroxylation of progesterone to yield 17α-hydroxyprogesterone and then
androstenedione), which drops earlier in the maturation cycle; follicle stimulating
hormone receptor (FSHr; key gonadotropin responsible for ovarian development), which
has low expression in the cortical alveolus stage; P450 aromatase (converts T to E2), or
CYP19a1, which is evenly expressed through all stages prior to dropping at late
maturation; and estrogen receptor α (ESR1; the only estrogen receptor subtype that has
been linked to vitellogenin synthesis in liver and E2 regulation (Chakraborty et al.,
2011)), which has no significant differences in expression over the ovarian development
stages, prior to dropping at late maturation. CYP19a1 and ESR1 follow the general
increasing pattern of E2 throughout the stages of maturation, whereas CYP17 and FSHr
do not. The lack of increase in the expression of CYP17 throughout recrudescence in
mummichog may be explained by the lack of an E2 to MIS switch at maturation, as the
expression patterns of CYP17 were previously suggested to have a role in the switch
(Clelland and Peng, 2009). CYP19a1 is suspected to be an estrogen-responsive gene; the
drop off in CYP19a1 expression at late maturation does not follow E2 patterns and
warrants further studies to determine what may be causing the decrease in CYP19a1.
CYP19b (P450 aromatase in brain) on the other hand, showed no significant differences
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in expression across ovarian development, suggesting regulation of local brain E2
production is independent of gonadal steroidogenesis. The results from this study suggest
that ESR1 expression is closely related to E2 levels and vitellogenin expression within
mummichog; however, the relationships for estrogen receptors ER2a and ER2b with
ovarian development are still unclear.
To determine EE2 effects on maturing follicles, grouped follicles were exposed to
50-250 nM of EE2 for 24 hours, in vitro, with and without hCG stimulation. There was no
effect on either T or MIS production (E2 was not measured due to high cross-reactivity to
EE2 in the EIA analysis), or gene expression (CYP19a1 and LHr) at any follicular stage.
The results validate the hypothesis that mummichog are more tolerant to EE2 than other
teleosts, as previous studies demonstrated an increase in LHr expression in zebrafish
ovarian cells after EE2 in vitro exposure (Liu et al., 2013). hCG stimulation increased
both hormone production and CYP19a1 expression in incubated follicles. It was
unexpected, however, that hCG stimulation did not increase LHr expression at either
stage of maturation (cortical alveolus – late mature), as MIS levels did increase with hCG
stimulation and Liu et al.’s (2013) study demonstrated hCG caused an increase in LHr
expression. The hormone and gene expression results after EE2 in vitro exposure adds
weight to the idea that mummichog ovarian follicles are resistant to exogenous estrogen.
Overall, the current study provided confirmation of a continuously increasing
production of E2 in maturing follicles, supplemented by new molecular analysis of key
steroidogenic enzymes and hormone/gonadotropin receptors across the ovarian
steroidogenic pathway in mummichog. These results, along with no effect of exposure to
EE2 on maturing follicles, support the hypothesis that high estrogen levels during oocyte
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maturation may be responsible for reduced sensitivity in mummichog to environmental
estrogens. However, the mechanism behind the correlation of high estrogen levels during
oocyte maturation and reduced sensitivity to exogenous estrogens need to be explored
further.
3.2 Future Directions
It has been demonstrated that mummichog are fairly resistant to exogenous
estrogens such as EE2, when compared to commonly-studied teleost species. Growth and
reproductive processes in freshwater teleosts, such as fathead minnow (Pimephales
promelas), zebrafish (Danio reiro), and Chinese rare minnow (Gobiocypris rarus), are
negatively impacted by exogenous estrogens at environmentally-relevant EE2
concentrations (ex. 0.1-10 ng/L) (Armstrong et al., 2016; Kidd et al., 2007; Lin and Janz,
2006; Parrott and Blunt, 2005; Zha et al., 2008). However, mummichog respond to much
higher concentrations at 100 ng/L or higher (if at all) (Bosker et al., 2016; Gillio Meina et
al., 2013; Hogan et al., 2010). Currently, the reason for this species-specific sensitivity
with EE2 is unknown. This thesis aimed to determine if continuously high levels of E2
present in maturing mummichog ovarian follicles were partially responsible for the
decreased sensitivity to EE2; results from this thesis have supported this hypothesis. In
order to further investigate this suggestion, similar experiments from this thesis can be
conducted on teleosts that are generally more tolerant to EE2 exposure, such as
sheepshead minnow (Cyprinodon variegates; Zillioux et al., 2001), in order to determine
if similar patterns of E2 regulation exist during ovarian development.
The experimental work on EE2 in vitro exposure of mummichog ovarian follicles
paves the way for more in vitro analysis on the mechanisms of EE2 action. In vitro
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exposures of staged ovarian follicles to EE2 have not been completed on any fish species.
The concentrations used in the current study were chosen after a thorough literature
research on previous EE2 in vitro exposures conducted on hepatic or ovarian tissue/cells.
The lack of effect of EE2 on P450 aromatase (CYP19a1), LHr gene expression, or on T
and MIS hormone production suggests that mummichog ovarian follicles are resistant to
EE2 exposure at 50-250 nM. It would be beneficial to assess the effect of EE2 at a broader
concentration range (e.g., 10 pM – 10 uM), as this range is commonly found in EDC in
vitro exposures (Beitel et al., 2015; Eide et al., 2014; Hultman et al., 2015; Liu et al.,
2013), or to run a concentration-response curve prior to choosing a new concentration
range. It would also be beneficial to assess the effect of EE2 in vitro in mummichog
follicles across a time course from 0 – 24 hours, at much shorter and intermediary
intervals, to determine if there are any molecular effects occurring at a shorter time
period than 24 hours. This is because EDCs can act on a molecular level within minutes
(membrane receptors) or hours (nuclear receptors) (Thomas, 2008) and as well that
effects can be transient (Shanle and Xu, 2011; Vandenberg et al., 2012). In the current
study, expression of CYP19a1 decreased after the 24-hour incubation, and although LHr
expression did not decrease after the 24-hour incubation, it is important to determine
what is happening to CYP19a1 expression before the 24-hour time period, as changes in
expression can occur rapidly and are transient. Noting these changes in expression prior
to the 24-hour incubation time point can be vital in determining the rate of perturbation
on CYP19a1 expression across stages of follicular development. Perhaps there is an
important piece missing with changes in LHr expression as well, which might provide
insight on why LHr expression does not decrease after 24 hours of incubation, or increase
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with hCG stimulation. A positive control could also be added to this study to confirm the
effect of EE2 on the measured endpoints. Because the mechanism of EE2 on mummichog
ovarian follicles is not yet known, zebrafish follicles could be used as a positive control
as it was demonstrated that EE2 has a negative effect on LHr expression in zebrafish
ovarian cells (Liu et al., 2013).
As previous EE2 in vitro exposures have been completed on hepatic cells (Beitel
et al., 2015; Eide et al., 2014), it would also be interesting to conduct an EE2 in vitro
exposure on liver tissue sampled at various stages of ovarian development, while
assessing vitellogenin and ERα expression changes. Brain sections could also be
dissected at various stages of ovarian development, to assess P450 aromatase in the brain,
as well as gonadotropin receptors and/or estrogen receptors. The data could be analyzed
alongside gene expression data from the current study measured in liver and brain at
different stages of ovarian development. This research could then be utilized to compile a
better understanding of how EE2 is affecting, or not affecting, mummichog through the
HPG axis.
In the current study, key receptors and enzymes in the steroidogenic pathway in
mummichog were characterized by molecular analysis for the first time. This work is
important to support further development of the mummichog model for EDC bioassay
work. Estrogen receptors, gonadotropin receptors, vitellogenin, StAR and P450 enzymes
were characterized across ovarian development in mummichog; however, there are still
some important genes in the steroidogenic pathway which could be characterized, such as
20β-HSD (20β-hydroxysteroid dehydrogenase), which catalyzes the conversion of 17αhydroxy progesterone to produce MIS (Young et al., 2005). As high levels of MIS
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coincide with high levels of E2 in mummichog, it would be interesting to see how 20βHSD (20β-hydroxysteroid dehydrogenase) is expressed across maturation. The current
study, along with previous work, emphasizes the importance of developing a thorough
understanding of comparative endocrinology and physiology among model teleost
species used in EDC studies. There are other endpoints which can be measured across the
ovarian development cycle in order to develop a full working model of mummichog;
these endpoints include furthering the molecular characterization of steroidogenic
enzymes, signaling pathways, and also more hormones and gonadotropins, etc. (Table
3.1). Measuring the levels of FSH and LH through EIA (enzymatic immunoassay)
analysis will be beneficial to see what is happening to these gonadotropins and whether
their levels correspond with receptor expression. Since LHr showed no increase in
expression after hCG stimulation in the current study, an analysis of the gonadotropin LH
with EE2 exposure across ovarian development may provide more insight into this
question. Filling in the knowledge gaps for mummichog physiology, as well as expanding
on EE2 exposure studies, will bring us closer to determining the mechanisms of tolerance
of estrogenic EDCs in mummichog.
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Table 3.1. Gap analysis chart of endpoints for developing the mummichog model across
the ovarian development cycle. Endpoints highlighted in green have been completed in
this study; endpoints highlight in pink have not been completed by any study.
Characterization of
Hormones,
Gonadotropins, etc.
E2
T
MIS
FSH
LH
VTG
Progesterone
Intracellular cAMP levels
PKA levels

Molecular
Characterization of
Signaling Pathways
ERα
ERβ1
ERβ2
VTG1
FSHr
LHr
G-protein coupled receptor

Molecular
Characterization of
Steroidogenic Enzymes
StAR
P450scc
P450c17
P450arom
3β-HSD
11β-HSD
17β-HSD
20β-HSD

Further studies need to be completed in order to determine the mechanistic reason
for why higher E2 levels during oocyte development may cause reduced sensitivity to
exogenous estrogens, such as EE2. A possible mechanism behind this correlation could be
associated with estrogen receptors. Ligand binding to ERs is responsible for regulating
the basic biology of estrogen-sensitive tissues; the use of selective agonists or antagonists
can modulate this biology (Rich et al., 2002). Therefore, binding activity is an important
factor to consider. ER competitive binding assays (assess a chemical’s ability to bind to
an ER) between E2 and EE2 have been completed in other species and could be a valuable
asset to understanding the mechanistic effects of EDCs in mummichog (Blair et al.,
2000). This could determine whether exogenous estrogens, such as EE2, are capable of
acting through the same binding mechanisms as endogenous E2. Eventually this would
demonstrate whether E2 has a higher binding affinity to ERs than EE2 in mummichog,
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and thus is displacing EE2 from ERs more so than in other fish. Further studies could also
be completed on the binding affinity of E2 and EE2 to the different ER subtypes within
various tissues, to get a more thorough understanding of the mechanisms.
Throughout this thesis, nuclear estrogen receptors were examined thoroughly.
More work could be completed on membrane receptors and explore the pKA (protein
kinase)/cAMP (cyclic AMP) pathway further. Ligand binding results in the exchange of
GDP for GTP on the Galphas protein; its dissociation from the BY subunit complex
stimulates the enzyme adenyl cyclase (AC) to catalyze the cyclization of ATP to generate
cAMP and pyro-phosphate (Serezani et al., 2008). Intracellular levels of cAMP are
tightly regulated by AC and the enzyme phosphodiesterase (PDE) (Serezani et al., 2008).
An increase in intracellular cAMP levels is an important intracellular signaling
mechanism involved in the regulation of gene expression (Chen et al., 1999); and
elevation in intracellular cAMP levels in the ovary is also important in the regulation of
steroid production, prior to GVBD in synergism with E2 (Lu et al., 2017). This leads to
the question of whether or not there is an increase in cAMP levels in maturing
mummichog follicles prior to maturation. A thorough characterization of the enzymes in
this pathway and intracellular cAMP levels can provide insight on whether the link
between reduced sensitivity to exogenous estrogens and high levels of E2 in maturing
oocytes is correlated to a component of this pathway.
There is also a possibility that the high E2 levels present in maturing mummichog
oocytes could be a result of adaptation to the environment or due to its asynchronous
spawning nature. In asynchronous spawners, the pre-vitellogenic, vitellogenic and
maturation phases almost completely overlap, with vitellogenesis and maturation
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occurring simultaneously; however, in synchronous spawners, the phases are clear with
little or no overlap, and in group-synchronous spawners, phases are less clear than
synchronous spawners and there is little overlap (Wooton and Smith, 2015). These
different patterns in oocyte dynamics can be caused by either radically different control
mechanisms for clear distinct phases, or a shift in temporal patterns for non-distinct
phases (Wooton and Smith, 2015). It would be interesting to determine what selective
factors cause these dynamic changes in oocyte development and maturation, through
evolutionary analysis of the species mummichog.

3.3 Integrative Nature of this Study
This study expanded the current understanding of reproductive physiology in
mummichog by linking endpoints across various biological levels. These include the
whole organism (e.g., hormone levels from blood (plasma)), organ (e.g., gonad size, liver
size, characterization of ovarian stage through histological analysis,), physiological (e.g.,
hormonal production from ovarian tissue and follicles) and molecular (e.g., gene
expression of various steroidogenic enzymes and receptors in different tissues) levels.
The endocrine system is one of the key signalling integrators in organisms; a thorough
assessment across these biological levels enhances our understanding for mummichog
and general fish reproductive physiology. This study also analyzed the effects of EE2 on
mummichog ovarian follicles across maturation, which furthers our interpretation of EE2
effects under various reproductive circumstances (e.g., at different stages of ovarian
development).
With the results from this study, we can develop a better understanding of
mechanisms of action of EDCs and link these results to the field of toxicology. We can
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utilize the results gained from this study to support the development of toxicological tools
that investigate the mechanisms of action of EDCs, including those compounds that,
similar to EE2, have estrogenic mechanisms of action. The knowledge of the mechanism
of action of certain substances can also supplement other studies which have addressed
these issues on a larger ecological scale. Through integration, the work from this study
can be utilized to determine the effect of EDCs (such as EE2) at various biological levels
across species, the mechanisms of action or tolerance of EE2 across species, and
ultimately can lead to improving risk assessment of pollutants (such as exogenous
estrogens) over a large scale, and protection of Canadian water systems.
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